<SEC-DOCUMENT>0001683168-24-000018.txt : 20240102
<SEC-HEADER>0001683168-24-000018.hdr.sgml : 20240102
<ACCEPTANCE-DATETIME>20240102160526
ACCESSION NUMBER:		0001683168-24-000018
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20240206
FILED AS OF DATE:		20240102
DATE AS OF CHANGE:		20240102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Forward Industries, Inc.
		CENTRAL INDEX KEY:			0000038264
		STANDARD INDUSTRIAL CLASSIFICATION:	PLASTICS PRODUCTS, NEC [3089]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				131950672
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34780
		FILM NUMBER:		24502387

	BUSINESS ADDRESS:	
		STREET 1:		700 VETERANS MEMORIAL HWY, SUITE 100
		CITY:			HAUPPAUGE
		STATE:			NY
		ZIP:			11788
		BUSINESS PHONE:		631-547-3055

	MAIL ADDRESS:	
		STREET 1:		700 VETERANS MEMORIAL HWY, SUITE 100
		CITY:			HAUPPAUGE
		STATE:			NY
		ZIP:			11788

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FORWARD INDUSTRIES INC
		DATE OF NAME CHANGE:	19950105

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROGRESS HEAT SEALING CO INC
		DATE OF NAME CHANGE:	19721111
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>forward_def14a.htm
<DESCRIPTION>FORM DEF 14A
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:FORD="http://forwardindustries.com/20230930">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_ECD%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_FORD_forwardindustries.com_20230930 -->
<!-- Field: Set; Name: xdx; ID: xdx_04E_20221001_20230930 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0000038264 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-10-01to2023-09-30" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-10-01to2023-09-30" name="dei:EntityCentralIndexKey">0000038264</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-10-01to2023-09-30" id="xdx2ixbrl0010" name="dei:DocumentType">DEF 14A</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ford-20230930.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-10-01to2023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012022-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType7Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType7Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType7Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType7Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType7Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType7Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType7Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType7Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000015" toRefs="Footnote000040"></ix:relationship>
  <ix:relationship fromRefs="Fact000027" toRefs="Footnote000040"></ix:relationship>
  <ix:relationship fromRefs="Fact000017" toRefs="Footnote000043"></ix:relationship>
  <ix:relationship fromRefs="Fact000021" toRefs="Footnote000043"></ix:relationship>
  <ix:relationship fromRefs="Fact000029" toRefs="Footnote000043"></ix:relationship>
  <ix:relationship fromRefs="Fact000033" toRefs="Footnote000043"></ix:relationship>
  <ix:relationship fromRefs="Fact000019" toRefs="Footnote000044"></ix:relationship>
  <ix:relationship fromRefs="Fact000031" toRefs="Footnote000044"></ix:relationship>
  <ix:relationship fromRefs="Fact000023" toRefs="Footnote000045"></ix:relationship>
  <ix:relationship fromRefs="Fact000035" toRefs="Footnote000045"></ix:relationship>
  <ix:relationship fromRefs="Fact000025" toRefs="Footnote000046"></ix:relationship>
  <ix:relationship fromRefs="Fact000037" toRefs="Footnote000046"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-size: 7pt"><a href="#toc">Table of Contents</a></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_905_edei--DocumentType_dxL_c20221001__20230930_zz3T5wFF11lf" title="::XDX::DEF%2014A"><span style="-sec-ix-hidden: xdx2ixbrl0010">SCHEDULE 14A</span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Rule 14a-101)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Proxy Statement Pursuant to Section&#160;14(a)
of the Securities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Exchange Act of 1934 (Amendment No.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 208px">&#160;</td>
    <td style="width: 32px">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed by Registrant</span></td>
    <td><span style="font-family: Wingdings; font-size: 10pt">&#254;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed by Party other than Registrant</span></td>
    <td><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check the appropriate box:</span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%"><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td style="width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary Proxy Statement</span></td>
    <td style="width: 5%"><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td style="width: 43%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidential, for Use of the Commission</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only (as permitted by Rule&#160;14a-6(e)(2))</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Wingdings; font-size: 10pt">&#254;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive Proxy Statement</span></td>
    <td><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive Additional Materials</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting Materials Pursuant to &#167;240.14a-12</span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_909_edei--EntityRegistrantName_c20221001__20230930_zDEFlVkerT17" style="font-size: 12pt"><b><ix:nonNumeric contextRef="From2022-10-01to2023-09-30" name="dei:EntityRegistrantName">FORWARD
INDUSTRIES, INC.</ix:nonNumeric></b></span><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Registrant as Specified In Its Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Person(s) Filing Proxy Statement, if other
than the Registrant)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment of Filing Fee (Check the appropriate box):</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Wingdings; font-size: 10pt">&#254;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No fee required.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 90%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of each class of securities to which transaction applies:</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate number of securities to which transaction applies:</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule&#160;0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$_____ per share as determined under Rule&#160;0-11 under the Exchange Act.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposed maximum aggregate value of transaction:</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total fee paid:</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee paid previously with preliminary materials.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%"><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td style="width: 95%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check box if any part of the fee is offset as provided by Exchange Act Rule&#160;0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form&#160;or Schedule and the date of its filing.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 5%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount previously paid:</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form, Schedule or Registration Statement No.:</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing Party:</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date Filed:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Forward Industries, Inc. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>700 Veterans Memorial Highway, Suite 100</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Hauppauge, New York 11788</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>_________________________</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To The Shareholders of Forward Industries, Inc.:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are pleased to invite you
to attend the 2024 Annual Meeting of the Shareholders of Forward Industries, Inc. (the &#8220;Annual Meeting&#8221;) which will be held
at 10:00 a.m. on February 6, 2024, at the offices of CohnReznick, 1301 Avenue of the Americas, Seventh Floor, in New York, New York. At
the Annual Meeting, our shareholders will be asked:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 35px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To elect three members to our Board of Directors.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 35px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To ratify the appointment of our independent registered public accounting firm for fiscal year 2024.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">To approve an amendment to our Restated Certificate of Incorporation
    to authorize a reverse stock split of our issued and outstanding shares of common stock at a ratio to be determined in the
    discretion of our Board of Directors within a range of one-for-two through one-for three (the &#8220;Reverse Split&#8221;). </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">To approve an adjournment of the Annual Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if there are not sufficient votes at the time of the Annual Meeting to approve any of the proposals presented for a vote at the Annual Meeting. </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">For the transaction of such other matters as may properly come before the Annual Meeting or any adjournment or postponement thereof.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shareholders of record as of the close of business
on December 22, 2023 are entitled to vote at the annual meeting and any postponement or adjournment thereof. Please see pages 1-2 for
additional information regarding accessing the Annual Meeting and how to vote your shares. You do not need to attend the meeting to vote
your shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Your vote is important. Please vote your proxy
promptly to ensure your shares are properly represented, even if you plan to join the annual meeting. You can vote by Internet, by telephone,
or by using the enclosed proxy card.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify"><b>We appreciate your continued confidence
in our Company and look forward to your joining us on February 6, 2024.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.9in; text-align: justify"><span style="text-decoration: underline">By the Order of the Board of Directors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.9in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.9in; text-align: justify">/s/ Terence Wise</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.9in; text-align: justify">Terence Wise</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.9in; text-align: justify">Chief Executive Officer</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dated: January 2, 2024</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Important Notice Regarding the Availability
of Proxy Materials for the Annual Meeting of Shareholders to Be Held on February 6, 2024: This Proxy Statement and Form 10-K are available
at: https://www.proxyvote.com</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>If You Plan to Attend</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please note that space limitations
make it necessary to limit attendance to shareholders. Registration and seating will begin at 9:00 a.m. Shares can be voted at the meeting
only if the holder is present in person or by valid proxy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For admission to the meeting,
each shareholder may be asked to present valid picture identification, such as a driver&#8217;s license or passport, and proof of stock
ownership as of the record date, such as the enclosed proxy card or a brokerage statement reflecting stock ownership. Cameras, recording
devices and other electronic devices will not be permitted at the meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you do not plan on attending
the meeting, please vote your shares via the Internet, by phone or by signing and dating the enclosed proxy and return it in the business
envelope provided. Your vote is very important.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>REVIEW THE PROXY STATEMENT AND VOTE IN FOUR
WAYS:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="text-align: center; vertical-align: top; width: 8%"><span style="font-family: Sans-Serif; font-size: 9pt"><b>&#160;<img src="image_001.jpg" alt="" /></b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 42%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>VIA THE INTERNET IN ADVANCE</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Visit&#160;<span style="text-decoration: underline">www.proxyvote.com.</span></p></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="text-align: center; vertical-align: top; width: 8%">
    <img src="image_002.jpg" alt="" /><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b></b></p></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 39%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>BY MAIL</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sign, date, and return the enclosed proxy card or voting instruction
    form.</p></td></tr>
  <tr>
    <td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td style="text-align: center; vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;<img src="image_003.jpg" alt="" /></p></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>BY TELEPHONE</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Call the telephone number on your proxy&#160;card or voting instruction
    form.</p></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center; vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><img src="image_004.jpg" alt="" /></b></p></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>AT THE MEETING</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attend the annual meeting virtually.&#160;<i>See page 1 for additional
    details on how to attend.</i></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Whether or not you expect to attend in person,
we urge you to vote your shares at your earliest convenience. This will ensure the presence of a quorum at the meeting. Promptly voting
your shares via the Internet, by phone or by signing, dating, and returning the enclosed proxy card will save us the expenses and extra
work of additional solicitation. An addressed envelope for which no postage is required if mailed in the United States is enclosed if
you wish to vote by mail. Submitting your proxy now will not prevent you from voting your shares at the meeting if you desire to do so,
as your proxy is revocable at your option. Your vote is important, so please act today!</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="toc"></span><b>TABLE OF CONTENTS </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#questions">Questions and Answers Regarding the Annual Meeting of Shareholders</a></b></span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#prop1">PROPOSAL 1. ELECTION OF DIRECTORS</a></b></span></td>
    <td style="text-align: right">7</td></tr>
  <tr>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#prox13">DIRECTORS AND EXECUTIVE OFFICERS</a></b></span></td>
    <td style="text-align: right">7</td></tr>
  <tr>
    <td style="text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#prox01">Corporate Governance</a></b></span></td>
    <td style="text-align: right">9</td></tr>
  <tr>
    <td style="text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#prox02">Committees of the Board of Directors</a></b></span></td>
    <td style="text-align: right">10</td></tr>
  <tr>
    <td style="text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#prox03">Compensation of Directors</a></b></span></td>
    <td style="text-align: right">13</td></tr>
  <tr>
    <td style="text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#prox04">Executive Compensation</a></b></span></td>
    <td style="text-align: right">14</td></tr>
  <tr>
    <td style="text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#prox05">Summary Compensation Table</a></b></span></td>
    <td style="text-align: right">14</td></tr>
  <tr>
    <td style="text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#prox06">Named Executive Officer Employment Compensation Arrangements/Agreements</a></b></span></td>
    <td style="text-align: right">15</td></tr>
  <tr>
    <td style="text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#prox07">Outstanding Equity Awards At Fiscal Year-End 2023</a></b></span></td>
    <td style="text-align: right">17</td></tr>
  <tr>
    <td style="text-indent: 0.5in">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#prox08">PROPOSAL 2. RATIFICATION OF THE APPOINTMENT OF OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL YEAR 2024</a></b></span></td>
    <td style="vertical-align: top; text-align: right">20</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#prox09">PROPOSAL 3. REVERSE SPLIT</a></b></span></td>
    <td style="vertical-align: top; text-align: right">22</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#prox10">PROPOSAL 4. ADJOURNMENT</a></b></span></td>
    <td style="vertical-align: top; text-align: right">28</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#prox11">OWNERSHIP OF OUR STOCK</a></b></span></td>
    <td style="text-align: right">29</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#prox12">OTHER MATTERS</a></b></span></td>
    <td style="text-align: right">31</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Forward Industries, Inc. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>700 Veterans Memorial Highway, Suite 100</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Hauppauge, New York 11788</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(631) 547-3041</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2024 ANNUAL MEETING OF SHAREHOLDERS </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROXY STATEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="questions"></span>Why am I receiving these material</b>s?</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These proxy materials are
being sent to the holders of shares of the voting stock of Forward Industries, Inc., which we refer to as &#8220;Forward&#8221; or the
&#8220;Company,&#8221; in connection with the solicitation of proxies by our Board of Directors, which we refer to as the &#8220;Board,&#8221;
for use at the 2024 Annual Meeting of Shareholders to be held at 10:00 a.m. on February 6, 2024 at 1301 Avenue of the Americas, Seventh
Floor, in New York. The proxy materials relating to the Annual Meeting are first being mailed to shareholders entitled to vote at the
meeting on or about January 2, 2024. A copy of our Form 10-K for the year ended September 30, 2023 is being mailed concurrently with this
Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Who is Entitled to Vote?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.15in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board has fixed the close
of business on December 22, 2023 as the record date for a determination of shareholders entitled to notice of, and to vote at, this Annual
Meeting or any adjournment thereof. On the record date, there were 10,061,185 shares of common stock outstanding. Each share of Forward
common stock represents one vote that may be voted on each matter that may come before the Annual Meeting. As of the record date, Forward
has no outstanding preferred stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>What is the difference between holding shares
as a record holder and as a beneficial owner?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If your shares are registered
in your name with our transfer agent, Equiniti Trust Company, LLC, you are the &#8220;record holder&#8221; of those shares. If you are
a record holder, these proxy materials have been provided directly to you by Forward.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If your shares are held in
a stock brokerage account, a bank or other holder of record, you are considered the &#8220;beneficial owner&#8221; of those shares held
in &#8220;street name.&#8221; If your shares are held in street name, these proxy materials have been forwarded to you by that organization.
As the beneficial owner, you have the right to instruct that organization on how to vote your shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Who May Attend the Meeting?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Record holders and beneficial
owners may attend the Annual Meeting. If you are the beneficial owner of shares held in street name, you should refer to the voting instructions
provided by your brokerage firm, bank, or other holder of record. Beneficial owners may also attend and vote online during the annual
meeting. <b><span style="text-decoration: underline">We encourage you to vote your proxy by Internet, by phone or by mail prior to the meeting, even if you plan to attend the
Annual Meeting.</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>How Do I Vote?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify"><i>Record Holder</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 35px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Vote by Internet</span>. The website address for Internet voting is on your proxy card.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 35px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Vote by phone</span>. Call 1 (800) 690-6903 and follow the instructions.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 35px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Vote by mail</span>. Mark, date, sign and promptly mail the enclosed proxy card (a postage-paid envelope is provided for mailing in the United States).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 35px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Vote in person</span>. Attend and Vote at the Annual Meeting.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in">If you vote by Internet or phone, please DO NOT mail your
proxy card.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in"><i>Beneficial Owner (Holding Shares in Street Name)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 35px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Vote by Internet</span>. The website address for Internet voting is on your voting instruction form.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 35px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Vote by phone</span>. Call 1 (800) 690-6903 and follow the instructions.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 35px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Vote by mail</span>. Mark, date, sign and promptly mail the enclosed voting instruction form (a postage-paid envelope is provided for mailing in the United States).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 35px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Vote in person</span>. Obtain a valid proxy from the organization that holds your shares and attend and vote at the Annual Meeting.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>What Constitutes a Quorum?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To carry on the business of
the Annual Meeting, we must have a quorum. A quorum is present when a majority of the shares entitled to vote, as of the record date,
are present in person or represented by proxy. Shares owned by Forward are not considered outstanding or considered to be present at the
Annual Meeting. Broker non-votes (because there are routine matters presented at the Annual Meeting) and abstentions are counted as present
for the purpose of determining the existence of a quorum.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>What happens if Forward is unable to obtain
a Quorum?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a quorum is not present
to transact business at the Annual Meeting or if we do not receive sufficient votes in favor of the proposals by the date of the Annual
Meeting, the persons named as proxies may propose one or more adjournments of the Annual Meeting to permit solicitation of proxies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35in 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>What happens if I do not give specific voting
instructions?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Record Holder. </b>If you
are a shareholder of record and you indicate when voting on the Internet or by telephone that you wish to vote as recommended by the Board,
or you sign, date and return a proxy card without giving specific voting instructions, then your shares will be voted in accordance with
the Board&#8217;s recommendations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Beneficial Owners. </b>If
you are a beneficial owner of shares held in street name and do not provide the organization that holds your shares with specific voting
instructions, the organization that holds your shares may generally vote at its discretion on routine matters but cannot vote on non-routine
matters. If the organization that holds your shares does not receive instructions from you on how to vote your shares on a non-routine
matter, the organization will not have the authority to vote your shares on that proposal. This is generally referred to as a &#8220;broker
non-vote.&#8221; In tabulating the voting results for any particular proposal, shares that constitute broker non-votes are not considered
entitled to vote on that proposal. Thus, broker non-votes will not affect the outcome of any matter being voted on at the meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Important Rule Affecting Beneficial Owners
Holding Shares In Street Name</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Brokers may no longer use
discretionary authority to vote shares on the election of directors. Please submit your voting instruction form so your vote is counted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Which Proposals are Considered &#8220;Routine&#8221;
or &#8220;Non-Routine&#8221;?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Proposals 2, 3 and 4 are considered
routine, and Proposal 1 is considered non-routine. A broker or other nominee cannot vote without instructions on non-routine matters,
and, therefore, there may be broker non-votes on Proposal 1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>How Many Votes are Needed for Each Proposal
to Pass and what is the effect of a Broker Non-Vote and Abstention?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border: black 1pt solid; padding-left: 3pt; width: 37%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposals</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt; width: 21%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Vote </b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Required</b></p></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt; width: 21%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Broker Discretionary Votes Allowed </b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt; width: 21%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Effect of Abstentions (1) </b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 3pt">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt">&#160;</td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Election of Directors</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plurality, which means that the three nominees receiving the highest number of affirmative votes will be elected.</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No. However, broker non-votes have no effect on this proposal.</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No effect</span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ratification of Independent Registered Public Accounting Firm</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Majority of the shares present in person or represented by proxy at the meeting and entitled to vote</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Same as a vote &#8220;Against&#8221;&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval of an amendment to the Restated Certificate of Incorporation to effect a Reverse Stock Split</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Majority of outstanding shares of common stock</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Same as a vote &#8220;Against&#8221;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjournment of the Annual Meeting</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Majority of the shares present in person or represented by proxy at the meeting and entitled to vote </span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Same as a vote &#8220;Against&#8221;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_________________<b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify; width: 96%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Withhold&#8221; for Proposal 1. If you &#8220;withhold&#8221; authority to vote with respect to one or more director nominees, your vote will have no effect on the election of such nominees.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>What Are the Voting Procedures?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In voting by proxy with regard
to the election of directors, you may vote in favor of all nominees, withhold your votes as to all nominees, or withhold your votes as
to specific nominees. With regard to the remaining proposals, you may vote in favor of each proposal or against each proposal, or in favor
of some proposals and against others, or you may abstain from voting on any of these proposals. You should specify your respective choices
on the accompanying proxy card or your voting instruction form.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Is My Proxy Revocable?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Record Holder</b>. You
may revoke your proxy and reclaim your right to vote up to and including the day of the Annual Meeting by giving written notice to the
Corporate Secretary of Forward, by delivering a proxy card dated after the date of the proxy or by voting during the Annual Meeting. All
written notices of revocation and other communications with respect to revocations of proxies should be addressed to: Forward Industries,
Inc., 700 Veterans Memorial Highway, Suite 100, Hauppauge, New York 11788, Attention: Corporate Secretary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Beneficial Owners</b>.
If you are the beneficial owner of shares held in street name, you must follow the instructions provided by your broker, bank, or other
holder of record for changing or revoking your proxy. Beneficial owners, other than plan participants as outlined below, may also attend
and vote online during the annual meeting, which will replace any previous votes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0; text-align: justify"><b>Who is Paying for the Expenses Involved
in Preparing and Mailing this Proxy Statement?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of the expenses involved
in preparing, assembling and mailing these proxy materials and all costs of soliciting proxies will be paid by Forward. In addition to
the solicitation by mail, proxies may be solicited by our officers and regular employees by telephone or in person. Such persons will
receive no compensation for their services other than their regular salaries. Arrangements will also be made with brokerage houses and
other custodians, nominees and fiduciaries to forward solicitation materials to the beneficial owners of the shares held by such persons
of record, and we may reimburse such persons for reasonable out of pocket expenses incurred by them in so doing. We may hire an independent
proxy solicitation firm.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>What Happens if Additional Matters are Presented
at the Annual Meeting?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other than the items of business
described in this Proxy Statement, we are not aware of any other business to be acted upon at the Annual Meeting. If you submit a signed
proxy card, the persons named as proxy holders, Mr. Terence Wise and Ms. Kathleen Weisberg, will have the discretion to vote your shares
on any additional matters properly presented for a vote at the Annual Meeting. If for any reason any of our nominees is not available
as a candidate for director, the persons named as proxy holders will vote your proxy for such other candidate or candidates as may be
nominated by the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>What is &#8220;householding&#8221; and how
does it affect me?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Record holders who have the
same address and last name will receive only one copy of their proxy materials, unless we are notified that one or more of these record
holders wishes to continue receiving individual copies. This procedure will reduce our printing costs and postage fees. Shareholders who
participate in householding will continue to receive separate proxy cards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you are eligible for householding,
but you and other record holders with whom you share an address, receive multiple copies of these proxy materials, or if you hold Forward
stock in more than one account, and in either case you wish to receive only a single copy of each of these documents for your household,
please contact our Corporate Secretary at: Forward Industries, Inc., 700 Veterans Memorial Highway, Suite 100, Hauppauge, New York 11788
or (631) 547-3041.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you participate in householding
and wish to receive a separate copy of these proxy materials, or if you do not wish to continue to participate in householding and prefer
to receive separate copies of these documents in the future, please contact our Corporate Secretary as indicated above. Beneficial owners
can request information about householding from their brokers, banks or other holders of record.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Do I Have Dissenters&#8217; (Appraisal) Rights?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Appraisal rights are not available
to Forward shareholders with any of the proposals brought before the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Can a Shareholder Present a Proposal To Be
Considered At the Next Annual Meeting?</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you wish to submit a proposal
to be considered at the 2025 Annual Meeting (&#8220;2025 Meeting&#8221;), the following is required:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For a shareholder proposal to be considered for inclusion in Forward&#8217;s
Proxy Statement and proxy card for the 2025 Meeting pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, which we refer to
as the &#8220;Exchange Act,&#8221; our Corporate Secretary must receive the written proposal no later than September 4, 2024, which is
120 calendar days prior to the one year anniversary date Forward&#8217;s Proxy Statement was mailed to shareholders in connection with
this Annual Meeting. Such proposals also must comply with SEC regulations under Rule 14a-8 regarding the inclusion of shareholder proposals
in company sponsored materials.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Bylaws include advance notice provisions that require shareholders desiring to recommend or nominate individuals to the Board or who wish to present a proposal at the 2025 Meeting must do so in accordance with the terms of the advance notice provisions. For a shareholder proposal or a nomination that is not intended to be included in Forward&#8217;s Proxy Statement and proxy card under Rule 14a-8, our Corporate Secretary must receive the written proposal no later than 120 calendar days nor more than 150 calendar days prior to the first anniversary of this year&#8217;s Annual Meeting; Provided, however, that in the event that the 2025 Meeting is changed more than 30 days before or after such anniversary date, the proposal must be received no earlier than the close of business on the 120th day prior to the 2025 Meeting and not later than the 90th date prior to the Meeting or the 10th day following the day on which public announcement of the date of such meeting is first made by the Company. If a shareholder fails to meet these deadlines and fails to satisfy the requirements of Rule 14a-8 under the Exchange Act, we may exercise discretionary voting authority under proxies we solicit to vote on any such proposal as we determine appropriate. Your notice must contain the specific information set forth in our Bylaws.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally, you must be a record holder at the time you deliver your notice to the Corporate Secretary and are entitled to vote at the 2025 Meeting and meet the ownership requirements contained in Section 208 of our Bylaws.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A nomination or other proposal
will be disregarded if it does not comply with the above procedures. All proposals and nominations should be sent to Forward Industries,
Inc., 700 Veterans Memorial Highway, Suite 100, Hauppauge, New York 11788, Attention: Corporate Secretary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We reserve the right to amend
our Bylaws and any change will apply to the 2025 Meeting unless otherwise specified in the amendment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify"><b>Interest of Officers and Directors
in Matters to Be Acted Upon</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except in the election to
our board of nominees set forth herein, none of the officers or directors have any interest in any of the matters to be acted upon at
the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>YOUR VOTE IS IMPORTANT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please vote your proxy promptly
so your shares can be represented, even if you plan to attend the Annual Meeting. You can vote by Internet, by telephone, or by using
the enclosed proxy card.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our proxy tabulator, Broadridge
Financial Solutions, must receive any proxy that will not be voted at the Annual Meeting by 11:59 p.m. New York time on February 5, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.05in; text-align: justify; text-indent: 0.15in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify"><b>The Board unanimously recommends
that shareholders vote &#8220;<span style="text-decoration: underline">For</span>&#8221; the election to the Board of each of the nominees in Proposal 1, and &#8220;<span style="text-decoration: underline">For</span>&#8221;
Proposals 2, 3 and 4. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.05in; text-indent: 0.15in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.05in; text-indent: 0.15in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.05in; text-indent: 0.15in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.05in; text-indent: 0.15in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.05in; text-indent: 0.15in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.05in; text-indent: 0.15in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: center"><b><span id="prop1"></span>PROPOSAL 1. ELECTION OF DIRECTORS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Forward&#8217;s shareholders
elect the Board members annually, and all of our current directors were elected by our shareholders to serve for a term expiring at this
Annual Meeting. James Ziglar is not seeking re-election to the Board effective as of this Annual Meeting. We thank Mr. Ziglar for his
contributions and many years of service to Forward.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board proposes and recommends
the election of the following nominees as directors:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Sangita Shah</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Sharon Hrynkow</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Terence Wise</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of the nominees
listed above have agreed to serve if elected. The three persons who receive the most votes cast will be elected and will serve as directors
until the next Annual Meeting. If a nominee becomes unavailable for election before this Annual Meeting, the Board can name a substitute
nominee and proxies will be voted for such substitute nominee unless an instruction to the contrary is written on the proxy card. Furthermore,
we may appoint an additional person to our Board before the Annual Meeting. The principal occupation and certain other information about
the nominees and our executive officers are set forth on the following pages.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: center"><b>The Board recommends a vote &#8220;<span style="text-decoration: underline">For</span>&#8221;
the election of the nominated slate of directors.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: center"><b><span id="prox13"></span>DIRECTORS AND EXECUTIVE OFFICERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table represents
our Board as of the record date (all, except James Ziglar, are Board nominees).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 26%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 34%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Appointed</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #EEEEEE">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sangita Shah</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 2015</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharon Hrynkow</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 2022</span></td></tr>
  <tr style="vertical-align: top; background-color: #EEEEEE">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Terence Wise</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 2012</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James Ziglar</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 2018</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Director Nominee Biographies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Sangita Shah</b>. Ms. Shah currently serves
as director and owner of Odyssean Enterprises Limited, a private advisory and investment company, in addition to serving as non-executive
chairman of Kinovo PLC, a leading UK provider of specialist property services centered on safety and regulatory compliance and non-executive
chairman of RA International PLC, a leading provider of services to remote locations in Africa and the Middle East. Ms. Shah is lead
director of Inspired PLC, UK's leading energy and sustainability advisor, and board director and chair of ESG for Ten Entertainment plc.,
an operator of entertainment centres. Ms. Shah also serves as a board director of Quoted Companies Alliance which represents over 90%
of small and midsized market cap FTSE companies. Ms. Shah is also a board advisor to Global Reach Technology, a Fast Track WiFi company.
Ms. Shah previously worked in seed/mezzanine financing and strategic investments within the environmental and technology sectors following
a number of senior roles held at KPMG and Ernst &amp; Young. Ms. Shah was selected as a director for her board and accounting experience,
and she also serves as our Lead Director. .</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Sharon Hrynkow</b>. Dr. Sharon Hrynkow is Founder
and Managing Partner of Global Health Consulting, LLC, an advisory group assisting clients on federal funding opportunities and strategies
to grow life science companies. Prior roles include Chief Scientific Officer and&#160;Senior VP for Medical Affairs at Cyclo
Therapeutics (Nasdaq: CYTH) where she launched and led its drug development programs (2015 to 2022); a range of senior executive positions
in global health and global science at the National Institutes of Health and Department of State (1992 &#8211; 2012); and, as inaugural
president of the Global Virus Network, a non-profit group working to combat the spread of viral disease (2012 &#8211; 2015).&#160; Dr.
Hrynkow is an elected member of the Council on Foreign Relations and an elected Fellow of the American Association for the Advancement
of Science. She advises a range of non-profit organizations on science and health matters, including the National Academies of Sciences,
Engineering and Medicine, and has served as an appointee to the President&#8217;s Council of Advisors on Science and Technology. Dr. Hrynkow
was selected as a director for her organizational leadership and management expertise as well as her global scientific networking experience.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Terence Wise</b>. Mr. Wise was appointed as
the Company&#8217;s Chief Executive Officer and Chairman of the Company&#8217;s Board of Directors since July 2015. Mr. Wise serves as
principal and Chairman of The Justwise Group Limited (&#8220;Justwise&#8221;) which he founded in 1977. Mr. Wise also serves as a principal
and owner of Forward Industries Asia-Pacific Corporation (&#8220;Forward China&#8221;), a buying and supplier agent in the Asia-Pacific
region and has significant shareholdings in two furniture manufacturing plants in China. See the section titled &#8220;Related Person
Transactions&#8221; below. Mr. Wise was selected as a director for his extensive experience in the Asian markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Executive Officers of Forward Industries, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 31%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 37%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 21%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Appointed</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #EEEEEE">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Terence Wise</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 2015</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kathleen Weisberg</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 2023</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See above for Mr. Terence Wise&#8217;s biography.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.05in; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Kathleen Weisberg. </b>Ms. Weisberg
was appointed the Company&#8217;s Chief Financial Officer effective July 1, 2023. Prior to her appointment as Chief Financial Officer,
Ms. Weisberg served as the Company&#8217;s Corporate Controller from June 2020 to June 2023. From June 2017 to June 2020, Ms. Weisberg
served as the Controller for Jungle Bob Enterprises, Inc., a reptile and aquarium product company. From December 2003 to March 2010, Ms.
Weisberg served as the Senior Manager for SEC Reporting at WW International, Inc., formerly Weight Watchers International, Inc. From October
1998 to November 2003, Ms. Weisberg served as Senior Auditor and Corporate Accounting Manager for Symbol Technologies, Inc., a manufacturer
and supplier of mobile data capture and delivery equipment. From January 1992 to October 1998, Ms. Weisberg was an auditor at Ernst &amp;
Young LLP. <b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0"><b>Executive Officers of Subsidiaries</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0.05in; text-align: justify"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 31%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 37%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Current Position</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 21%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Appointed</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #EEEEEE">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Severino</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President of IPS</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tom KraMer</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer of Kablooe, Inc.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td></tr>
  <tr style="vertical-align: top; background-color: #EEEEEE">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert Wild</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer of IPS</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0.05in; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Paul Severino</b>. Mr. Severino served as the
Chief Operating Officer of Intelligent Product Solutions, Inc. (&#8220;IPS&#8221;) since co-founding it in 2007 until January 1, 2022
when he was appointed President of IPS.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0.05in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Tom KraMer</b>. Mr. KraMer has served as the
President and Chief Executive Officer of Kablooe, Inc. since the Company&#8217;s acquisition of the assets of Kablooe Design, Inc. in
August 2020. Prior to that, Mr. KraMer served as the Chief Executive Officer of Kablooe Design, Inc. since its formation in 1991.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Robert Wild</b>. Mr. Wild has served as the
Chief Operating Officer of IPS since January 1, 2022. Prior to that Mr. Wild served as the Senior Vice President of IPS.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no family relationships between any
of the executive officers and directors. Our Bylaws require that each director is elected at our annual meeting of shareholders and holds
office until the next annual meeting of shareholders, or until his or her successor is elected. See the section titled &#8220;Related
Person Transactions&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="prox01"></span>Corporate Governance</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Board Responsibilities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board oversees, counsels,
and directs management in the long-term interest of Forward and its shareholders. The Board&#8217;s responsibilities include establishing
broad corporate policies and reviewing the overall performance of Forward. The Board is not, however, involved in the operating details
on a day-to-day basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Board Committees and Charters</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board delegates various
responsibilities and authority to different Board committees (&#8220;Board Committees&#8221;). The Board and the Board&#8217;s committees
(&#8220;Committees&#8221;) meet throughout the year and act by written consent from time-to-time as appropriate. Committees regularly
report on their activities and actions to the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.65in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board currently has and
appoints the members of the Audit and Risk Committee (the &#8220;Audit Committee&#8221;), the Compensation Committee and the Nominating
and Governance Committee. Each of these Committees has a written charter which may be accessed through Forward&#8217;s website at: https://www.forwardindustries.com/investors/governance/.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table identifies
the independent and non-independent Board and Committee members:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 29%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Independent</b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit and Risk</b></span></td>
    <td style="vertical-align: top; width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></td>
    <td style="vertical-align: top; width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominating and Governance</b></span></td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sangita Shah</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#215;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chair</span></td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#215;</span></td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#215;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharon Hrynkow </span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#215;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#215;</span></td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chair</span></td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#215;</span></td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Terence Wise</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Meetings Held</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There were seven Board meetings
held in fiscal 2023. All of the directors attended over 75% of the applicable Board and Committee meetings held in fiscal 2023. The Company
does not have a policy regarding Board members attending annual meetings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Director Independence</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in; text-align: justify; text-indent: 0.2in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board has determined that
Sangita Shah and Sharon Hrynkow are independent in accordance with standards under the Nasdaq Listing Rules. Our Board determined that
as a result of being employed as an executive officer and the transactions described on page 12, Mr. Wise was not independent under the
Nasdaq Listing Rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board has also determined
that Sangita Shah and Sharon Hrynkow are independent under the Nasdaq Listing Rules independence standards for Audit Committee members
and Compensation Committee members.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center; text-indent: -0.2in"><b><span id="prox02"></span>Committees of
the Board of Directors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.2in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Audit Committee </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee reviews
our financial reporting process on behalf of the Board and administers our engagement of the independent registered public accounting
firm. The Audit Committee meets with the independent registered public accounting firm, with and without management present, to discuss
the results of its examinations, the evaluations of our internal controls, and the overall quality of our financial reporting. Management
has the primary responsibility for the financial statements and the reporting process, including the system of internal controls.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt"><i>Audit Committee Financial Expert</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board has determined that
Ms. Shah is qualified as an Audit Committee Financial Expert, as that term is defined by the rules of the Securities and Exchange Commission
(the &#8220;SEC&#8221;) and in compliance with the Sarbanes-Oxley Act of 2002.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0.05in; text-align: justify; text-indent: 0.3in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Compensation Committee</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The function of the Compensation
Committee is to make recommendations to the Board concerning Board and committee compensation. The Compensation Committee is also responsible
for oversight of our overall compensation plans and benefit programs, as well as the approval of all employment, severance and change
of control agreements and plans applicable to our executive officers. The Compensation Committee is also responsible for determining the
compensation of and compensation structure for all of the Company&#8217;s executive officers. The Compensation Committee reviews and approves
equity-based compensation grants to our officers, directors, employees and consultants in accordance with the Company&#8217;s equity incentive
plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Nominating and Governance Committee</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The responsibilities of the
Nominating and Governance Committee include the identification of individuals qualified to become Board members, establishing the procedures
for the nomination process and the selection of nominees to stand for election as directors, the oversight of the selection and composition
of committees of the Board, oversight of possible conflicts of interests involving the Board and its members, developing policies and
procedures for related party transactions, developing corporate governance principles, and the oversight of the evaluations of the Board
and management specifically with respect to Corporate Governance. The Nominating and Governance Committee has not established a policy
with regard to the consideration of any candidates recommended by shareholders. If we receive any shareholder recommended nominations,
the Nominating and Governance Committee will carefully review the recommendation(s) and consider such recommendation(s) in good faith.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Board Diversity</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While we do not have a formal
policy on diversity, our Board considers diversity to include the skill set, background, reputation, type and length of business experience
of our board members, as well as a particular nominee&#8217;s contribution to that mix. Although there are many other factors, the Board
seeks individuals with experience in the sourcing industry and Asian markets, sales and marketing, legal and accounting skills and board
experience. The Board and the Nominating and Governance Committee also seek individuals with diversity of race, ethnicity and gender.
Please refer to our Board Diversity Matrix which may be accessed on our website at https://forwardindustries.com/investors/governance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Board Leadership Structure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board has determined that
its current structure, with combined Chairman and Chief Executive Officer roles and an independent Lead Director (Sangita Shah), is in
the best interests of Forward and its shareholders at this time. A number of factors support the leadership structure chosen by the Board,
including, among others:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Chief Executive Officer is intimately involved in the day-to-day operations of Forward and is best positioned to elevate the most critical business issues for consideration by the Board.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Board believes that having the Chief Executive Officer serve in both capacities allows him to more effectively execute Forward&#8217;s strategic initiatives and business plans and confront its challenges. A combined Chairman and Chief Executive Officer structure provides us with decisive and effective leadership with clearer accountability to our shareholders. The combined role is both counterbalanced and enhanced by the effective oversight and independence of our Board and the independent leadership provided by our Lead Director. The Board believes that the appointment of a strong independent Lead Director and the use of regular executive sessions of the non-management directors, along with the Boards strong committee system, allow it to maintain effective oversight of management.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Role of Board in Risk Oversight</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our risk management function is
overseen by our Board. Our management keeps the Board apprised of material risks and provides directors access to all information necessary
for them to understand and evaluate how these risks interrelate, how they affect us, and how management addresses those risks. Terence
Wise, as our Chief Executive Officer and Chairman of the Board, and Kathleen Weisberg, our Chief Financial Officer, work closely together
with the Board, the Audit Committee and our Lead Director (who is also a member and Chair of the Audit Committee), on how to best address
identified risks. If the identified risk poses an actual or potential conflict with management, our independent directors may conduct
the assessment. Presently, the primary risks affecting us are: (i) our ability to grow our business and (ii) increasing our customer base.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify"><b>Code of Business Conduct and Ethics</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board has adopted a Code
of Business Conduct and Ethics (&#8220;Code of Ethics&#8221;) that applies to all of our employees, including our Chief Executive Officer
and Chief Financial Officer. Although not required, the Code of Ethics also applies to our Board. The Code of Ethics provides written
standards that we believe are reasonably designed to deter wrongdoing and promote honest and ethical conduct, including the ethical handling
of actual or apparent conflicts of interest between personal and professional relationships, full, fair, accurate, timely and understandable
disclosure, and compliance with laws, rules and regulations, including insider trading, corporate opportunities and whistle-blowing or
the prompt reporting of illegal or unethical behavior. A copy of our Code of Ethics may be accessed at https://forwardindustries.com/investors/governance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: justify"><b>Anti-Hedging Policies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify; text-indent: 0.5in">Under the Company&#8217;s
Insider Trading Policy, all officers, directors and employees are prohibited from engaging in hedging, pledging or shoring transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Communication with our Board of Directors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0.05in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we do not have a
formal policy regarding communications with the Board, shareholders may communicate with the Board by writing to us at Forward Industries,
Inc., 700 Veterans Memorial Highway, Suite 100, Hauppauge, New York 11788, Attention: Corporate Secretary, or by facsimile (631) 676-7748.
Shareholders who would like their submission directed to a member of the Board may so specify, and the communication will be forwarded,
as appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Delinquent Section 16(a) Reports </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 16(a) of the Exchange
Act requires our directors, executive officers, and persons who beneficially own more than 10% of our common stock to file initial reports
of ownership and changes in ownership of our common stock and other equity securities with the SEC. These individuals are required by
the regulations of the SEC to furnish us with copies of all Section 16(a) forms they file. Based solely on a review of the copies of the
forms furnished to us, and written representations from reporting persons, we believe that all filing requirements applicable to our officers,
directors and 10% beneficial owners were complied with during the fiscal year ended September 30, 2023, except for one Form 4 (one transaction)
which Mr. Robert Wild failed to file.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Related Person Transactions </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has a Buying Agency
and Supply Agreement (the &#8220;Supply Agreement&#8221;) with Forward China. Terence Wise, the Company&#8217;s Chairman, Chief Executive
Officer and largest shareholder, is the owner of Forward China. In addition, Jenny P. Yu, a Managing Director of Forward China, owns more
than 5% of the Company&#8217;s common stock. The Supply Agreement provides that Forward China will act as the Company&#8217;s exclusive
buying agent and supplier of products in the Asia Pacific region. The Company purchases products at Forward China&#8217;s cost and pays
Forward China a monthly fee for services it provides under the Supply Agreement. The monthly service fee is calculated at $100,000 plus
4% of &#8220;Adjusted Gross Profit.&#8221;, which is defined as the selling price less the cost from Forward China. The Company recorded
service fees to Forward China of approximately $1,266,000 and $1,398,000 during fiscal 2023 and 2022, respectively. The supply agreement
expired October 22, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November 2, 2023, Forward
and Forward China entered into a Buying Agency and Supply Agreement (the &#8220;New Agreement&#8221;). The New Agreement provides that
Forward China will act as Forward&#8217;s exclusive buying agent and supplier of products in the Asia Pacific region. Forward purchases
products at Forward China&#8217;s cost and pays Forward China a monthly fee for services it provides under the New Agreement. The monthly
service fee is $65,833 plus 4% of &#8220;Adjusted Gross Profit&#8221;, which is defined as the revenues recognized by Forward from the
sale of the product less Forward China&#8217;s cost for the product. The New Agreement expires October 31, 2024. The New Agreement is
substantially similar to the Supply Agreement (disclosed above) except for the reduced monthly fee payable to FC ($100,000 reduced to
$65,833).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, on November
2, 2023, Forward and Forward China entered into a Deferred Payment Agreement. As of October 30, 2023, Forward owed Forward China $7,365,238
for the purchase of products in its OEM and Retail Divisions and the cancelation of open purchase orders related to Forward&#8217;s exit
from the Retail Division. To preserve Forward&#8217;s liquidity position in the future, Forward China agreed to limit the amount of the
Payables that it would seek to collect from Forward to $500,000 in any 12-month period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In October 2020, the Company
began selling smart-enabled furniture, which is sourced by Forward China and sold in the U.S. under the Koble brand name. The Koble brand
is owned by Justwise Group Ltd. (&#8220;Justwise&#8221;), a company owned by Mr. Wise. The Company recognized revenues from the sale of
Koble products of $2,058,000 and $1,741,000 in fiscal 2023 and fiscal 2022, respectively. The agreement expired in August 2023. Effective
September 1, 2023, on November 3, 2023, Forward and Justwise, entered into an agreement to extend this agreement. Under this agreement,
Justwise provides inventory management, marketing support and other consulting services. In consideration of their services, Forward pays
Justwise $10,000 per month. This agreement was on a month-to-month basis and was terminated in December 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 16 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has an arrangement
with Happ LLC (&#8220;Happ&#8221;), whose principal owner is the daughter of Ms. Yu, whereby the Company purchases products directly from
Forward China and ships the product directly to Happ. In consideration for these services, the Company is paid a 3.0% fee on the total
cost of the product. Revenue recognized from Happ was approximately $626,000 and $780,000 in fiscal 2023 and fiscal 2022, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The sister of Paul Severino,
the President of IPS, is employed by IPS as its Chief Marketing Officer and received total compensation of approximately $120,000 and
$125,000 in fiscal 2023 and fiscal 2022, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To fund the acquisition of
IPS, the Company issued a $1.6 million promissory note to Forward China in consideration for a one-year loan. The note was originally
due January 18, 2019 but has been subsequently extended several times and is now due on December 31, 2024.&#160;&#160; The note bears
an interest rate of 8% and charges monthly interest.&#160;&#160; The Company made approximately $104,000 and $122,000 in interest payments
associated with the note in fiscal 2023 and fiscal 2022, respectively. In fiscal 2023, the Company made $300,000 of principal payments
on this note.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="prox03"></span>Compensation of Directors Table 2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In fiscal 2023, our non-employee
directors were compensated for as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name<br />
(a)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Fees Earned or</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Paid in</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Cash </b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($)(b)</b></p></td>
    <td style="border-bottom: black 1pt solid; width: 6%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Stock</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Awards</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($)(c)</b></p></td>
    <td style="border-bottom: black 1pt solid; width: 6%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Option</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Awards</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($)(d)(1)</b></p></td>
    <td style="border-bottom: black 1pt solid; width: 11%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Non-Equity</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Incentive</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Plan</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Compensation</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($)(e)</b></p></td>
    <td style="border-bottom: black 1pt solid; width: 11%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Change in</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pension</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Value and</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Nonqualified</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Deferred</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Compensation</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Earnings</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($)(f)</b></p></td>
    <td style="border-bottom: black 1pt solid; width: 11%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>All</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Other</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Compensation</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($)(g)</b></p></td>
    <td style="border-bottom: black 1pt solid; width: 11%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Total</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($)(j)</b></p></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: #EEEEEE">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sangita Shah</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,000</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="background-color: #EEEEEE">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharon Hrynkow</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,000</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="background-color: #EEEEEE">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James Ziglar </span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,000</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0">_______________________</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 2pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0pt"></td><td style="width: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
reported represent the aggregate grant date fair value of awards granted without regard to forfeitures, computed in accordance with ASC
718. This amount does not reflect the actual economic value realized by the directors.</span></td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 17 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="prox04"></span>Executive Compensation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following information
is related to the compensation earned in fiscal 2023 and 2022 by all Chief Executive Officers (principal executive officers) serving during
the last fiscal year and the other most highly compensated executive officers serving at the end of the last fiscal year whose compensation
exceeded $100,000. We refer to these individuals as our &#8220;Named Executive Officers&#8221; or &#8220;NEOs&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="prox05"></span>Summary Compensation Table </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 29%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Name and</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Principal Position</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(a)</b></p></td>
    <td style="vertical-align: top; width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 7%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(b)</b></p></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Salary </b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($)(c)(1)</b></p></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Bonus </b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($)(d)(2)</b></p></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Stock</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Awards</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($)(e)</b></p></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Option</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Awards</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($)(f)</b></p></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All Other Compensation<br />
($)(i)(3)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Total</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($)(j)</b></p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Terence Wise</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">325,000</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,000</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">337,000</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">318,750</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,000</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">330,750</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert Wild</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">271,250</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,118</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,043</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">351,411</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Officer of IPS</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">253,500</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,446</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,546</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">296,901</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Severino</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">278,750</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,397</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,118</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">370,264</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Officer of IPS</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">257,000</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,057</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,890</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">288,726</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tom KraMer</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,709</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">269,709</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Officer of Kablooe</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,558</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">275,558</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kathleen Weisberg</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,500</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,999</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,499</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">_________________________</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 5%"><span style="font-size: 10pt">(1)</span></td>
    <td style="width: 92%; text-align: justify"><span style="font-size: 10pt">Mr. Wise&#8217;s salary includes $1,000 per month for a
    total of $12,000 in lieu of reimbursement for company expenses. Ms. Weisberg was appointed Chief Financial Officer on July 1, 2023,
    and her salary is $250,000. Because of the date of Ms. Weisberg&#8217;s appointment, only three months compensation is disclosed
    above.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Represents cash bonuses.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">All other compensation for:</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify">(a) Mr. Wild represents (i) $10,000 in
    reimbursements for auto and phone allowances; (ii) Company contributions to 401k plans of $9,548; (iii) life insurance benefits provided
    by the Company of $495.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify">(b) Mr. Severino represents (i) $18,000
    of reimbursements for auto and phone allowances; (ii) Company contributions to 401k plans of $9,623; (iii) life insurance benefits provided
    by the company of $495.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify">(c) Mr. KraMer represents (i) the Company&#8217;s
    contribution to a 401(k) plan of $9,749; and (ii) a benefits allowance of $9,960.</p></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 18 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="prox06"></span>Named Executive Officer Employment Compensation
Arrangements/Agreements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-indent: 0.45in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Terence Wise</i></b>.
Effective May 16, 2018, the Company and Terence Wise entered into a three-year Employment Agreement. Pursuant to his Employment Agreement,
Mr. Wise received an annual base salary of $300,000. This Employment Agreement has expired. Mr. Wise is currently employed under an oral
agreement on terms identical to his prior Employment Agreement. In November 2021, Mr. Wise&#8217;s base salary was increased to $325,000
per year, effective January 1, 2022. Mr. Wise is also paid $1,000 per month to cover various expenses in the performance of his duties
as the Chairman and Chief Executive Officer of the Company. In December 2023, Mr. Wise agreed to a 25% reduction in his annual base
salary for fiscal 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Robert Wild</i></b>.
In connection with the acquisition of IPS, effective January 18, 2018, the Company entered into an at-will employment agreement with
Robert Wild. Pursuant to his Employment Agreement, Mr. Wild was paid an annual base salary of $235,000. Mr. Wild&#8217;s base salary
has since been increased to $275,000 per year. Mr. Wild receives an additional $10,000 per year for auto and cell phone allowance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Paul Severino</i></b>.
In connection with the acquisition of IPS, effective January 18, 2018, the Company entered into a three-year employment agreement with
Paul Severino. Under the employment Agreement, Mr. Severino received an annual base salary of $256,000 and $1,500 per month for auto and
cell phone allowance. In May 2021, the Company entered into a one-year employment agreement (which extends on each one-year anniversary
thereafter unless requisite notice is provided by either party), with Mr. Severino whereby he will be paid an annual base salary of $251,000
and will be eligible to receive cash bonuses and equity compensation based on performance milestones established by the Company&#8217;s
Compensation Committee. No such performance metrics have been set by the Compensation Committee. In 2022, Mr. Severino&#8217;s annual
base salary was increased to $275,000, which was effective July 1, 2022. Additionally, effective July 2023, Mr. Severino&#8217;s annual base salary was increased to $290,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.05in; text-align: justify; text-indent: 0.45in"><b>&#160;&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Tom KraMer</i></b>.
In connection with the acquisition of Kablooe, effective August 17, 2020, the Company entered into a five-year employment agreement with
Tom KraMer. Under the employment agreement, Mr. KraMer receives an annual base salary of $250,000 per year and is eligible to receive
cash or equity bonuses based on fiscal year performance targets established by the Compensation Committee of the Company&#8217;s Board
of Directors in its discretion. Under certain circumstances, Mr. KraMer would be entitled to receive six months base salary and other
benefits if his employment agreement is terminated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>Key Employee (Non-NEO under SEC Rules and Regulations)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Kathleen Weisberg</i></b>.
Effective July 1, 2023, the Company and Kathleen Weisberg, the Company&#8217;s Chief Financial Officer, entered into a three-year Employment
Agreement. Pursuant to her Employment Agreement, Ms. Weisberg is paid an annual base salary of $250,000 and is eligible to earn a bonus
based on certain fiscal targets and performance metrics set by the Compensation Committee of the Board in consultation with the Chief
Executive Officer. No such targets or performance metrics have been set by the Compensation Committee. Ms. Weisberg has termination provisions
substantially similar to the Named Executive Officers as described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Bonus</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each of the Named Executive
Officers is entitled to receive discretionary bonuses at the discretion of the Compensation Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-indent: 0.45in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Termination Provisions </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Messrs. Wise and Severino
would be entitled to receive six months base salary and other benefits if their respective employment agreement is terminated by the Company
without cause or by the executive for good reason. Mr. Wild is entitled to any accrued but unpaid base salary and other benefits if his
employment agreement is terminated without cause.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 19 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;Cause&#8221; under
Messers. Wise and Severino&#8217;s employment agreements generally means: (1) willful misconduct in connection with the performance of
any of his duties; (2) willful failure, neglect or refusal to perform his duties or services under the employment agreement, which failure,
neglect or refusal shall continue for a period of time after written notice has been given to the executive by or on behalf of the Board;
and (3) the commission of, conviction of, or nolo contendere or guilty plea in connection with, a felony or a crime of moral turpitude.
&#8220;Cause&#8221; under Mr. Wild&#8217;s employment agreement generally means: (1) dishonesty, illegal conduct, or gross misconduct;
(2) any commission of embezzlement, misappropriation, or fraud; (3) the conviction of, plea of guilty, or nolo contendere to a felony
or crime of moral turpitude; (4) willful and material failure to perform duties; (5) willful unauthorized disclosure of the Company&#8217;s
confidential information; (6) the material breach of the employment agreement; and (7) the material failure to comply with the Company&#8217;s
written policies or rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;Good reason&#8221;
under Mr. Severino&#8217;s employment agreement generally means: (1) the assignment to the executive without his consent of duties materially
inconsistent with such executive&#8217;s position; (2) any failure by the Company to perform any material obligation under, or its breach
of a material provision of, the employment agreement; or (3) the failure of a successor company to expressly assume the respective executive&#8217;s
employment agreement. &#8220;Good Reason&#8221; under Mr. Wise&#8217;s employment agreement generally means (1) the assignment to the
executive without his consent of duties materially inconsistent with such executive&#8217;s position; (2) a decrease in annual salary
rate, other than an across the board decrease in salary applicable to all senior executive of the Company of not more than 10%; (3) any
failure by the Company to perform any material obligation under, or its breach of a material provision of, the employment agreement; (4)
the failure of a successor company to expressly assume the respective executive&#8217;s employment agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Retirement Plans</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has a 401(k)
plan and provides an employer matching contribution, for all of its employees, including Named Executive Officers. The Company does not
offer any nonqualified pension plans, supplemental executive retirement plans, or other plans that provide for the payment of retirement
benefits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Outstanding Awards at Fiscal Year End </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Listed below is information
with respect to unexercised options, stock that has not vested, and equity incentive plan awards for each Named Executive Officer outstanding
as of September 30, 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 20 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="prox07"></span>Outstanding Equity Awards At Fiscal Year-End
2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of<br />
Securities<br />
Underlying<br />
Unexercised<br />
Options (#)<br />
Exercisable</b></span></td>
    <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of<br />
Securities<br />
Underlying<br />
Unexercised<br />
Options<br />
(#)<br />
Unexercisable</b></span></td>
    <td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity<br />
Incentive<br />
Plan<br />
Awards:<br />
Number of<br />
Securities<br />
Underlying<br />
Unexercised<br />
Unearned<br />
Options<br />
(#)</b></span></td>
    <td style="width: 7%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option<br />
Exercise<br />
Price</b></span></td>
    <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option<br />
Expiration<br />
Date</b></span></td>
    <td style="width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of<br />
Shares or<br />
Units of<br />
Stock That<br />
Have Not<br />
Vested (#)</b></span></td>
    <td style="width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market<br />
Value of<br />
Shares or<br />
Units of<br />
Stock That<br />
Have Not<br />
Vested</b></span></td>
    <td style="width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity<br />
Incentive<br />
Plan<br />
Awards:<br />
Number of<br />
Unearned<br />
Shares,<br />
Units or<br />
Other<br />
Rights That<br />
Have Not<br />
Vested (#)</b></span></td>
    <td style="width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity<br />
Incentive<br />
Plan<br />
Awards:<br />
Market or<br />
Payout<br />
Value of<br />
Unearned<br />
Shares,<br />
Units or<br />
Other<br />
Rights<br />
That<br />
Have Not<br />
Vested ($)</b></span></td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)</b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)</b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)</b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)</b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)(e)</b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(f)</b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(g)</b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)(h)</b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)</b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(j)</b></span></td></tr>
  <tr>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Terence Wise</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">180,395</span></td>
    <td style="text-align: center">&#8211;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.40</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/14/25</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td></tr>
  <tr style="background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert Wild</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,682</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.56</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/1/27</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td></tr>
  <tr style="background-color: White">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,572</span></td>
    <td style="text-align: center">&#8211;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.56</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/1/27</span></td>
    <td style="text-align: center">&#8211;</td>
    <td style="text-align: center">&#8211;</td>
    <td style="text-align: center">&#8211;</td>
    <td style="text-align: center">&#8211;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,363</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.56</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/1/27</span></td>
    <td style="text-align: center">&#8211;</td>
    <td style="text-align: center">&#8211;</td>
    <td style="text-align: center">&#8211;</td>
    <td style="text-align: center">&#8211;</td></tr>
  <tr style="background-color: White">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,535</span></td>
    <td style="text-align: center">&#8211;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.47</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/1/27</span></td>
    <td style="text-align: center">&#8211;</td>
    <td style="text-align: center">&#8211;</td>
    <td style="text-align: center">&#8211;</td>
    <td style="text-align: center">&#8211;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,817</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.47</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/1/27</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td></tr>
  <tr style="background-color: White">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,433</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.47</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/1/27</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Severino</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tom KraMer</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kathleen Weisberg</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risk Assessment Regarding Compensation Policies
and Practices as they Relate to Risk Management</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: justify">Our compensation program for employees
does not create incentives for excessive risk taking by our employees or involve risks that are reasonably likely to have a material adverse
effect on us. Our compensation has the following risk-limiting characteristics:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="width: 96%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our base pay programs consisting of competitive salary rates provide a reliable level of income on a regular basis, which decreases incentive on the part of our executives to take unnecessary or imprudent risks;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="width: 96%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Awards are not tied to formulas that could focus executives on specific short-term outcomes;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="width: 96%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity awards, when issued, may be recovered by us should a restatement of earnings occur upon which incentive compensation awards were based, or in the event of wrongdoing by the recipient; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="width: 96%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity awards, generally, have multi-year vesting which aligns the long-term interests of our executives with those of our shareholders and, again, discourages the taking of short-term risk at the expense of long-term performance.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, our Board has adopted a clawback
policy in accordance with the rules of the Nasdaq Stock Exchange, to recoup &#8220;excess&#8221; incentive compensation, if any, earned
by current and former executive officers during a three year look back period in the event of a financial restatement due to material
noncompliance with any financial reporting requirement under the securities laws (with no fault required).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 21 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Equity Compensation Plan Information </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following chart reflects the number of securities granted and the
weighted average exercise price for our compensation plans as of September 30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of Plan</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Number of securities to be issued upon exercise
    of outstanding options, restricted stock units, warrants and rights</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(a)</b></p></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted-average exercise </b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>price of </b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>outstanding options, warrants and rights</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>$ (b)</b></p></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Number of securities remaining available for
    future issuance under compensation plans (excluding securities reflected in column (a))</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(c)</b></p></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity compensation plans approved by security holders</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021 Equity Incentive Plan</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">401,676&#160;</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.49&#160;</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">889,320</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2011 Long Term Incentive Plan</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">521,055</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.38</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#8211;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity compensation plans not approved by security holders</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,084,658</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">889,320</span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">No more securities are being issued under the 2011 Long Term Incentive
Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pay-versus-Performance Table</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As required by Section 953(a) of the Dodd-Frank
Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation S-K, we are providing the following information about the
relationship between executive compensation actually paid and the Company&#8217;s financial performance. The amounts in the table below
are calculated in accordance with SEC rules and do not represent amounts actually earned or realized by our NEOs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<ix:nonNumeric contextRef="From2022-10-01to2023-09-30" escape="true" name="ecd:PvpTableTextBlock"><table cellspacing="0" cellpadding="0" summary="xdx: Disclosure - Pay vs Performance Disclosure" id="xdx_880_eecd--PvpTableTextBlock_zCwHOOMYSrs3" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year <br />
(a)</span></td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary Compensation Table Total for PEO<br />
(b)(1)($)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation Actually Paid to PEO<br />
(c)(2)</span>($)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average Summary Compensation Table Total for non-PEO Named Executive Officers<br />
(d)(3)($)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average Compensation Actually Paid to non-PEO Named Executive Officers<br />
(e)(2)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Value of Initial Fixed $100 Investment Based On Total Shareholder Return<br />
(f)(4)($)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Income<br />
(g)(5)($)</span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td>&#160;</td>
    <td colspan="2" id="xdx_98B_eecd--PeoTotalCompAmt_c20221001__20230930_fKDEp_zqQtPe4psy2j" title="PEO Total Compensation Amount" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2022-10-01to2023-09-30" id="Fact000015" format="ixt:numdotdecimal" decimals="0" unitRef="USD">337,000</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" id="xdx_98A_eecd--PeoActuallyPaidCompAmt_c20221001__20230930_fKDIp_zak8EVFFOrHg" title="PEO Actually Paid Compensation Amount" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2022-10-01to2023-09-30" id="Fact000017" format="ixt:numdotdecimal" decimals="0" unitRef="USD">337,000</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" id="xdx_986_eecd--NonPeoNeoAvgTotalCompAmt_c20221001__20230930_fKDMp_zs00p4juSeBc" title="Non-PEO NEO Average Total Compensation Amount" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2022-10-01to2023-09-30" id="Fact000019" format="ixt:numdotdecimal" decimals="0" unitRef="USD">304,945</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" id="xdx_983_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20221001__20230930_fKDIp_zGR7OdOH0Eve" title="Non-PEO NEO Average Compensation Actually Paid Amount" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2022-10-01to2023-09-30" id="Fact000021" format="ixt:numdotdecimal" decimals="0" unitRef="USD">302,996</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" id="xdx_98B_eecd--TotalShareholderRtnAmt_c20221001__20230930_fKDQp_zEgLrCi73ZL5" title="Total Shareholder Return Amount" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2022-10-01to2023-09-30" id="Fact000023" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" id="xdx_98B_eus-gaap--NetIncomeLoss_c20221001__20230930_fKDUp_zbyR4Q7I4o42" title="Net Income (Loss)" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-10-01to2023-09-30" id="Fact000025" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,716,651</ix:nonFraction>)</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_985_eecd--PeoTotalCompAmt_c20211001__20220930_fKDEp_zunmKWQV7Pzl" title="PEO Total Compensation Amount" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2021-10-012022-09-30" id="Fact000027" format="ixt:numdotdecimal" decimals="0" unitRef="USD">330,750</ix:nonFraction></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_987_eecd--PeoActuallyPaidCompAmt_c20211001__20220930_fKDIp_zzhj47NX7Aq6" title="PEO Actually Paid Compensation Amount" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2021-10-012022-09-30" id="Fact000029" format="ixt:numdotdecimal" decimals="0" unitRef="USD">330,750</ix:nonFraction></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_980_eecd--NonPeoNeoAvgTotalCompAmt_c20211001__20220930_fKDMp_znuzy8V7WhOh" title="Non-PEO NEO Average Total Compensation Amount" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2021-10-012022-09-30" id="Fact000031" format="ixt:numdotdecimal" decimals="0" unitRef="USD">286,498</ix:nonFraction></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_98E_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20211001__20220930_fKDIp_zQng5PCRwyy6" title="Non-PEO NEO Average Compensation Actually Paid Amount" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2021-10-012022-09-30" id="Fact000033" format="ixt:numdotdecimal" decimals="0" unitRef="USD">285,882</ix:nonFraction></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_988_eecd--TotalShareholderRtnAmt_c20211001__20220930_fKDQp_zNaUE6CtAjke" title="Total Shareholder Return Amount" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2021-10-012022-09-30" id="Fact000035" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56</ix:nonFraction></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_98C_eus-gaap--NetIncomeLoss_c20211001__20220930_fKDUp_zT66EFcc0EVf" title="Net Income (Loss)" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-10-012022-09-30" id="Fact000037" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,378,251</ix:nonFraction>)</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 16%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 11%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 11%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 11%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 11%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 11%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 11%">&#160;</td>
    <td style="width: 1%">&#160;</td></tr>
  </table></ix:nonNumeric>
<ix:nonNumeric contextRef="From2022-10-01to2023-09-30" escape="true" name="ecd:NamedExecutiveOfficersFnTextBlock"><p id="xdx_840_eecd--NamedExecutiveOfficersFnTextBlock_dU_zsrz1b8uRI97" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">______________</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span id="xdx_F05_z93jD5QSLc18" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify; width: 96%"><span id="xdx_F1F_zewWtGFk7Ote" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000040" xml:lang="en-US">Represents the amounts reported for <span id="xdx_908_eecd--PeoName_c20221001__20230930_zfxhn2CRcaT"><span id="xdx_90F_eecd--PeoName_c20211001__20220930_zcxEelDByyNl"><ix:nonNumeric contextRef="From2022-10-01to2023-09-30" name="ecd:PeoName"><ix:nonNumeric contextRef="From2021-10-012022-09-30" name="ecd:PeoName">Mr. Wise</ix:nonNumeric></ix:nonNumeric></span></span> (the &#8220;PEO&#8221;) in the &#8220;Total&#8221; column of the &#8220;Summary Compensation Table&#8221; in each applicable year. </ix:footnote></span></td></tr>
</table>

<p style="margin: 0">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span id="xdx_F04_zo5HwSt4c0E6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td id="xdx_F1C_ziVjTiN5dNyg" style="text-align: justify; width: 96%"><ix:footnote id="Footnote000043" xml:lang="en-US">SEC rules require certain adjustments be made to the &#8220;Summary Compensation Table&#8221; totals to determine &#8220;compensation actually paid&#8221; as reported in the &#8220;Pay Versus Performance&#8221; table above. For purposes of the equity award adjustments shown below, no equity awards were cancelled as a result of a failure to meet vesting conditions. The valuation assumptions used to calculate fair values for purposes of the compensation actually paid calculation did not materially differ from those disclosed at the time of grant (as applicable). The following table details the applicable adjustments to the amount in the &#8220;Total&#8221; column of the &#8220;Summary Compensation Table&#8221; in each applicable year that were made to determine &#8220;compensation actually paid&#8221; (all amounts are averages for the NEOs other than the PEO):</ix:footnote></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 22 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="display: none; margin-top: 0; margin-bottom: 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; display: none; text-align: center"></p><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; display: none; width: 100%"><tr style="display: none; vertical-align: top"><td style="display: none; width: 4%"><span id="xdx_F02_zpnafTwdXRLe" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt">(3)</span></td>
    <td style="display: none; text-align: justify; width: 96%"><span id="xdx_F1B_zYYlWZfqUa2l" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:footnote id="Footnote000044" xml:lang="en-US">Represents the average of the amounts reported for the named executive officers (NEOs) as a group (excluding the PEO) in the &#8220;Total&#8221; column of the &#8220;Summary Compensation Table&#8221; in each applicable year. The names of each of the NEOs included for these purposes for 2023 and 2022 are Anthony Camarda, Robert Wild, Paul Severino and Tom KraMer.</ix:footnote></span></td></tr>
</table>

<p style="margin: 0; display: none">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; display: none; width: 100%">
  <tr style="display: none; vertical-align: top">
    <td style="display: none; width: 4%"><span id="xdx_F01_zkujJW59oU0h" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt">(4)</span></td>
    <td style="display: none; text-align: justify; width: 96%"><span id="xdx_F18_zgxRZ7ecv2mg" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:footnote id="Footnote000045" xml:lang="en-US">Represents the cumulative total shareholder return of a fixed investment of $100 made at the closing price of the Company&#8217;s common stock at September 30, 2021 for the measurement period beginning on such date and continuing through and including the end of the applicable fiscal year reflected in the table.</ix:footnote></span></td></tr>
</table>

<p style="margin: 0; display: none">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; display: none; width: 100%">
  <tr style="display: none; vertical-align: top">
    <td style="display: none; width: 4%"><span id="xdx_F08_zYsOItQPIN4i" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt">(5)</span></td>
    <td style="display: none; text-align: justify; width: 96%"><span id="xdx_F1F_zkzAv4TKssd4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:footnote id="Footnote000046" xml:lang="en-US">Represents the amount of net loss reflected in the Company&#8217;s audited financial statements for the applicable fiscal year reflected in the table.</ix:footnote></span></td></tr></table>


</ix:nonNumeric><p id="xdx_859_z0trQx9LrJm9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<ix:nonNumeric contextRef="From2022-10-01to2023-09-30" escape="true" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock"><p id="xdx_89A_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zlsifGlJe078" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Relationship Between Compensation Actually
Paid and our Total Shareholder Return</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our stock price performance
is not one of the elements used in determining Compensation Actually Paid to our Named Executive Officers. However, the amount of Compensation
Actually Paid to our Named Executive Officers aligns with the Company&#8217;s Total Shareholder Return (TSR) due to the fact that a portion
of the compensation paid to our Named Executive Officers is comprised of equity awards. In both 2023 and 2022, the amount of Compensation
Actually Paid to our Named Executive Officers was less than the Summary Compensation Table total for the Named Executive Officers due
to the decline in fair value of equity awards due in part to the declining stock price and TSR.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><p id="xdx_8AC_zh4aaBBfJ8Fb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-10-01to2023-09-30" escape="true" name="ecd:CompActuallyPaidVsNetIncomeTextBlock"><p id="xdx_897_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zu5kxKqi3YEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Relationship Between Compensation Actually
Paid and our Net Income (Loss)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">GAAP net income (loss) is a measure of our overall profitability that
we believe is a factor that can drive our stock price performance. However, Compensation Actually Paid is less sensitive to our annual
GAAP income (loss) because management and our Board does not believe that our GAAP income (loss) is the only meaningful measure in allowing
investors to evaluate management&#8217;s performance, primarily due to: (i) losses incurred by our now discontinued retail segment which
the Board believes was as a result of supply chain issues and the pandemic which were outside of the control of our NEOs and (ii) the
need to retain key executives with the skills to provide the leadership the Company needs to succeed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

</ix:nonNumeric><p id="xdx_8A4_z0YCUEXQ68wh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<ix:nonNumeric contextRef="From2022-10-01to2023-09-30" escape="true" name="ecd:AdjToPeoCompFnTextBlock"><p id="xdx_847_eecd--AdjToPeoCompFnTextBlock_dU_zytiXv6xtgp" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Year</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Name</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Summary</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Compensation</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Table Total</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Deduct
                                            &#8220;Stock</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Awards&#8221;
    and</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>&#8220;Option</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Awards&#8221;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>reported in</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Summary</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Compensation</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Table</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Add
                                            Year-</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>End Fair</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Value of</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Outstanding</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>and</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Unvested</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Equity</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Awards</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Granted in</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>the Year</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Add
                                            (Deduct)</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Year over</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Year Change</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>in Fair</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Value of</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Outstanding</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>and Unvested</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Equity</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Awards</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Granted in</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Prior Years</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Add
                                            Fair</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Value as of</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Vesting Date</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>of Equity</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Awards</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Granted and</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Vested in</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>the Year</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Add</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>(Deduct)</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Year over</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Year Change</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>in Fair Value</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>of Equity</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Awards</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Granted in</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Prior Years</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>which</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Vested in</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>the Year</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Add
                                            Value</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>of any</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Dividends</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>or Other</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Earnings</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Paid in</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>the Year</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Compensation</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Actually Paid</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 19%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">PEO</span></td>
    <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_986_eecd--PeoTotalCompAmt_c20221001__20230930_zAFWFGEd81nh" title="Summary Comp.Table Total for CEO" style="width: 6%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2022-10-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">337,000</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_98D_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType1Member_zaIYdNAytuQg" title="Summary Comp.Table Total for CEO" style="width: 6%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType2Member_zQxLOZU7iwA1" title="Summary Comp.Table Total for CEO" style="width: 6%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType2Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_98A_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType3Member_zfRvvYaME3o2" title="Summary Comp.Table Total for CEO" style="width: 6%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_98C_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType4Member_zBFcxB2Cpvnj" title="Summary Comp.Table Total for CEO" style="width: 6%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType4Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_98A_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType5Member_zmjH0KoiKOmg" title="Summary Comp.Table Total for CEO" style="width: 6%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType5Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType6Member_z20frLH60Nfi" title="Summary Comp.Table Total for CEO" style="width: 6%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType6Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_987_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType7Member_zd9xbeQk8rA8" title="Summary Comp.Table Total for CEO" style="width: 6%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType7Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">337,000</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other NEOs</span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_989_eecd--NonPeoNeoAvgTotalCompAmt_c20221001__20230930_zBsKPOAEoe3l" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2022-10-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">304,945</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_983_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType1Member_z6AdaeUPiUz4" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_982_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType2Member_zeduNCByvMza" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType2Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType3Member_zG29AeK9Zx0i" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType3Member" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,210</ix:nonFraction>)</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_987_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType4Member_zngEMF1uAVb" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType4Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType5Member_zkN6p0Vwi1Ub" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType5Member" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">739</ix:nonFraction>)</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_986_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType6Member_zzURSu7JyNQl" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType6Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_983_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType7Member_zQcIbIReSbQ6" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType7Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">302,996</ix:nonFraction></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">PEO</span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_982_eecd--PeoTotalCompAmt_c20211001__20220930_zhQzzGhso179" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2021-10-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">330,750</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_985_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType1Member_zIrAyk4ET7ul" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_982_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType2Member_zGSuWM8te49a" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType2Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_988_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType3Member_zpWdWuPpMutb" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_989_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType4Member_zkf2SssUjsJ9" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType4Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType5Member_zEIr9iRChxVg" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType5Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType6Member_zogKSv7PJr77" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType6Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_982_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType7Member_zFUCpOncRCv2" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType7Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">330,750</ix:nonFraction></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other NEOs</span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_982_eecd--NonPeoNeoAvgTotalCompAmt_c20211001__20220930_zbQSHayqaVpf" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2021-10-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">286,498</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_98D_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType1Member_zjmIjnqyT9Pi" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_987_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType2Member_zLhJ4JMQwWgh" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType2Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,717</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_988_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType3Member_zxkCJlrwaJZf" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_988_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType4Member_zAZhVmwtIPwa" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType4Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,667</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_98C_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType5Member_zIQzDjqxqpF4" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType5Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_988_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType6Member_z5UUG8KOJYec" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType6Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_982_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType7Member_zn6BFSJmDmni" title="Summary Comp.Table Total for CEO" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType7Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">285,882</ix:nonFraction></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 9pt">________________</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3)</span></td>
    <td style="text-align: justify; width: 96%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Represents the average of the amounts reported for the named executive officers (NEOs) as a group (excluding the PEO) in the &#8220;Total&#8221; column of the &#8220;Summary Compensation Table&#8221; in each applicable year. The names of each of the NEOs included for these purposes for 2023 and 2022 are Anthony Camarda, Robert Wild, Paul Severino and Tom Kramer.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Represents the cumulative total shareholder return of a fixed investment of $100 made at the closing price of the Company&#8217;s common stock at September 30, 2021 for the measurement period beginning on such date and continuing through and including the end of the applicable fiscal year reflected in the table.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Represents the amount of net loss reflected in the Company&#8217;s audited financial statements for the applicable fiscal year reflected in the table.</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_858_zNfwmdtbc9y8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: center"><b><span id="prox08"></span>PROPOSAL 2. RATIFICATION OF THE APPOINTMENT
OF OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL YEAR 2024</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board has appointed CohnReznick
LLP to serve as our independent registered public accounting firm for the fiscal year ending September 30, 2024. CohnReznick LLP has been
Forward&#8217;s independent registered public accounting firm since 2011. Selection of Forward&#8217;s independent registered public accounting
firm is not required to be submitted to a vote of the shareholders of Forward for ratification. However, Forward is submitting this matter
to the shareholders as a matter of good corporate governance. Even if the appointment is ratified, the Board may, in its discretion, appoint
a different independent registered public accounting firm at any time during the year if they determine that such a change would be in
the best interests of Forward and its shareholders. If the appointment is not ratified, the Board will consider its options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A representative of CohnReznick
LLP is expected to be present at the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>The Board recommends a vote &#8220;<span style="text-decoration: underline">For</span>&#8221;
this Proposal No. 2</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee, which
currently consists of Sangita Shah, Sharon Hrynkow and James Ziglar, reviews Forward&#8217;s financial reporting process on behalf of
the Board and administers our engagement of the independent registered public accounting firm. The Audit Committee meets with the independent
registered public accounting firm, with and without management present, to discuss the results of its examinations, the evaluations of
our internal controls, and the overall quality of our financial reporting. Management has the primary responsibility for the financial
statements and the reporting process, including the system of internal controls.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee has met
and held discussions with management and CohnReznick LLP. Management represented to the Audit Committee that our financial statements
were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;), and
the Audit Committee has reviewed and discussed the financial statements with management and CohnReznick LLP. The Audit Committee reviewed
with CohnReznick LLP its judgments as to the quality, not just the acceptability, of our accounting principles and such other matters
as are required to be discussed with the Audit Committee in accordance with the standards of the Public Company Accounting Oversight Board,
which we refer to as the &#34;PCAOB.&#34;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Audit Committee Report </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee has:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewed and discussed the audited financial statements with management;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">met privately with the independent registered public accounting firm and discussed matters required by the PCAOB;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">received the written disclosures and the letter from the independent registered public accounting firm, as required by the applicable requirements of the PCAOB regarding the independent registered public accounting firm&#8217;s communications with the Audit Committee concerning independence, and has discussed with the independent registered public accounting firm its independence from us; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in reliance on the review and discussions referred to above, recommended to the Board that the audited financial statements be included in the Annual Report on Form 10-K for the fiscal year ended September 30, 2023 filed with the SEC.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This report is submitted by
the Audit Committee:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Sangita Shah</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Sharon Hrynkow</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">James Ziglar</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The above Audit Committee
Report is not deemed to be &#8220;soliciting material,&#8221; is not &#8220;filed&#8221; with the SEC and is not to be incorporated by
reference in any filings that Forward files with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is not the duty of the
Audit Committee to determine that Forward&#8217;s financial statements and disclosures are complete and accurate and in accordance with
generally accepted accounting principles or to plan or conduct audits. Those are the responsibilities of management and Forward&#8217;s
independent registered public accounting firm. In giving its recommendation to the Board, the Audit Committee has relied on: (1) management&#8217;s
representations that such financial statements have been prepared with integrity and objectivity and in conformity with US GAAP; and (2)
the report of Forward&#8217;s independent registered public accounting firm with respect to such financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Audit Committee&#8217;s Pre-Approval Policy</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee pre-approves
all audit and permissible non-audit services on a case-by-case basis. In its review of non-audit services, the Audit Committee considers
whether the engagement could compromise the independence of our independent registered public accounting firm, and whether the reasons
of efficiency or convenience is in our best interest to engage our independent registered public accounting firm to perform the services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Fees incurred by Forward for the Services Provided by CohnReznick
LLP</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the aggregate fees paid for or accrued by Forward for audit and other services provided by CohnReznick LLP for the fiscal years ended
2023 and 2022:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.35in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2023</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($)</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2022</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($)</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-align: left">Audit Fees (1)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right">236,404</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right">211,140</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Audit Related Fees</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8211;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8211;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Tax Fees</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">21,203</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8211;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">All Other Fees</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&#8211;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&#8211;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">257,607</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">211,140</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%">&#160;</td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="width: 95%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit fees &#8211; these fees relate to the annual audits and quarterly reviews of our financial statements as well as services that are normally provided by the independent registered public accounting firm in connection with statutory and regulatory filings or engagements.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="prox09"></span>PROPOSAL 3. REVERSE SPLIT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
Board has adopted and submitted for stockholder approval an amendment to our Restated Certificate of Incorporation (our &#8220;Certificate&#8221;)
to authorize a Reverse Split of all outstanding shares of our common stock, if the Board deems that it is in our and our stockholders&#8217;
best interests, at a ratio to be determined by the Board in the range of one-for-two through one-for-three. Our Board will have the sole
discretion to elect, as it determines to be in the best interests of the Company and our stockholders, whether or not to effect a Reverse
Split, and if so, at which ratio within the approved range. Our Board believes that approval of a proposal granting this discretion to
the Board, rather than approval of an immediate Reverse Split at a specified ratio, would provide the Board with maximum flexibility to
react to current market conditions and other factors it deems appropriate and to therefore achieve the purposes of the Reverse Split,
if implemented, and to act in the best interests of the Company and our stockholders. <b>The Board will only effectuate a Reverse Split
if required to meet Nasdaq listing requirements.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Reverse Split has been proposed for approval at the Annual Meeting in order to attempt to remediate the Company&#8217;s current noncompliance
with Nasdaq&#8217;s minimum bid price requirement under Nasdaq Rule 5550(a)(2). On July 31, 2023, Nasdaq notified the Company that the
Company was not compliant with this requirement by failing to be above $1.00 per share for 30 consecutive trading days, and that the
Company has until January 29, 2024 to regain compliance by having a closing bid price of at least $1.00 per share for 10 consecutive
trading days, subject to a potential 180 calendar day extension of the grace period. The purpose of the Reverse Split is to regain compliance
with Nasdaq&#8217;s Rule and avoid delisting of our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In the event the Company does not evidence compliance with the minimum
bid price requirement for the requisite, minimum 10-consecutive trading day period by January 29, 2024, Nasdaq will issue a delist determination
on or about January 30, 2024. The Company may thereafter request a hearing before the Nasdaq Hearings Panel (the &#8220;Panel&#8221;),
which timely request will stay any further delisting action by Nasdaq at least until the hearing is held, the Panel issues a formal determination
following the hearing, and any extension that the Panel may grant to the Company as a result of the hearing expires.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">To
effect the Reverse Split, our Board would authorize our management to file a Certificate of Amendment to our Certificate with the Secretary
of State of New York. If our Board elects to implement the approved Reverse Split within the range, the number of issued and outstanding
shares of our common stock (as well as common stock underlying derivative securities such as options and warrants) would be reduced in
accordance with the ratio for the selected Reverse Split. The par value of our common stock would remain unchanged, however the number
of authorized and unissued shares of our common stock would increase as a result of the Reverse Split. If approved by our stockholders,
our Board may nonetheless elect not to implement the Reverse Split at its sole discretion. This could occur if our common stock regains
compliance with the Nasdaq Rule prior to the termination of the applicable grace period. The proposed form of amendment to our Certificate
to implement the Reverse Split is attached to this Proxy Statement as&#160;<span style="text-decoration: underline">Annex A</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><span style="text-decoration: underline">Purpose of the
Reverse Split</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
July 31, 2023, the Company received a letter from Nasdaq notifying the Company of its noncompliance with Nasdaq Rule 5550(a)(2) (by
failing to maintain a minimum bid price for its common stock of at least $1.00 per share for 30 consecutive trading days.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">According
to the letter, the Company has a 180-calendar day initial grace period to regain compliance with the Rule, subject to a potential 180
calendar day extension, as described below. To regain compliance, the Company&#8217;s common stock must have a minimum closing bid price
of at least $1.00 per share for at least 10 consecutive trading days within the grace period. In the event the Company does not regain
compliance by January 29. 2024, the end of the grace period, the Company may be eligible for an additional 180 calendar day grace period
to regain compliance. To qualify for the additional grace period, the Company will be required to meet the continued listing requirement
for the market value of its publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception
of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second grace
period, by effecting the Reverse Split if necessary. However, if it appears to Nasdaq at the end of the grace period that the Company
will be unable to cure the deficiency, or if the Company is not otherwise eligible for the additional cure period, Nasdaq will provide
notice that the Company&#8217;s common stock will be subject to delisting. As of the Record Date, the Company was not eligible to obtain
the 180-day extension.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">While
the letter had no immediate impact on the listing of the Company&#8217;s common stock, which has continued to be listed and traded on
The Nasdaq Capital Market, the Company is seeking stockholder approval of the Reverse Split to enable the Board to take action to attempt
to enable the Company to regain compliance with the Nasdaq Rule and continue to be listed on The Nasdaq Capital Market. By including Board
discretion to effect the Reverse Split within the range, the Company will be positioned to react to market conditions and actions taken
by Nasdaq to increase the Company&#8217;s chances of achieving this goal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Board has determined that maintaining listing on Nasdaq is an important goal, as the Board believes that the listing of our common stock
on a principal national securities exchange enhances the liquidity of the outstanding shares as well as the Company&#8217;s ability to
raise capital, each of which is considered to be a benefit to the Company and its stockholders. Additionally, the Board believes that
continued listing on Nasdaq enhances visibility and credibility to the investment community with respect to our common stock. If, on the
other hand, our common stock were delisted from Nasdaq and we were unable to list our securities on an alternative national securities
exchange, trading of our common stock would most likely take place on an over-the-counter market established for unlisted securities,
such as the OTCQB or a lower-tiered quotation system operated by The OTC Markets Group. In such an event, investors may find it more difficult
to sell shares of our common stock. The result could be a depressive effect on our stock price. In addition, if our common stock were
delisted, it would become subject to SEC rules regarding &#8220;penny stocks,&#8221; which impose additional disclosure requirements on
broker-dealers and further hindrances and expenses for investors seeking to sell the securities. For these reasons and others, delisting
would likely adversely affect the liquidity, trading volume and price of our common stock, causing the value of an investment in us to
decrease and having an adverse effect on our business and an investment in us, as well as on our ability to raise capital as and when
required.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">While
the Company hopes that approval of this Proposal 3 will enable it to regain compliance prior to the termination of the grace period, the
Company intends to monitor the bid price of its common stock and assess its options for maintaining the listing of its common stock on
The Nasdaq Capital Market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">For
more information on the risks inherent in the Reverse Split, including with respect to the Nasdaq deficiency notice and potential for
delisting, see below under the heading &#8220;Certain Risks Associated with the Reverse Split.&#8221; For additional information about
the risks we and our investors face with respect to our common stock, business and other matters, see &#8220;Item 1A. - Risk Factors&#8221;
in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023, a copy of which has been mailed with this Proxy Statement
to our stockholders of record as of the record date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Certain Risks Associated with the Reverse Split</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="text-decoration: underline">If the Reverse Split does
not result in a proportionate increase in the price of our common stock, we may be unable to regain compliance with the Nasdaq listing
requirements or meet those of another national securities exchange</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect that if approved
the Reverse Split will increase the market price of our common stock so that we will be able to regain compliance with Nasdaq&#8217;s
minimum bid price requirement. However, the effect of the Reverse Split on the market price of our common stock cannot be predicted with
certainty, and the results of reverse stock splits by companies under similar circumstances have varied. It is possible that the market
price of our common stock following the Reverse Split will not increase sufficiently for us to regain compliance with the minimum bid
price requirement. For example, if our stock price were to fall below $0.34 per share, the high end of the range of the Reverse Split,
which is one-for-three, would potentially be insufficient to enable us to comply with the minimum bid price requirement post-Reverse Split.
Further, the Reverse Split may result in a lesser number of round lot holders (holders of at least 100 shares), which could also cause
us to be noncompliant with another Nasdaq Rule requiring that we have at least 300 round lot holders. If we are unable meet the minimum
bid price requirement or other requirements under Nasdaq Rules, we may not be unable continue to have or common stock listed on Nasdaq,
and may be unable to list our common stock on an alternative national securities exchange. This could have a material adverse effect on
our liquidity and an investment in us, and impose additional hardships on investors seeking to sell our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="text-decoration: underline">Even if the Reverse Split
results in the requisite increase in the market price of our common stock, there is no assurance that we will be able to continue to comply
with the minimum bid price requirement</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Even if the Reverse Split
results in the requisite increase in the market price of our common stock to be in compliance with the minimum bid price requirements
of Nasdaq, there can be no assurance that the market price of our common stock following the Reverse Split will remain at the level required
for continued compliance with such requirement. It is not uncommon for the market capitalization of a company&#8217;s common stock to
decline in the period following a reverse stock split. If the market price of our common stock declines following the implementation of
the Reverse Split, the percentage decline may be greater than would occur in the absence of the Reverse Split. In any event, other factors
unrelated to the number of shares of our common stock outstanding, such as negative financial or operational results, could adversely
affect the market price of our common stock and jeopardize our ability to meet or continue to comply with the minimum bid price requirement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">The Reverse Split may decrease the liquidity
of our common stock</span>.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The liquidity of our common
stock may be adversely affected by the Reverse Split given the reduced number of shares that will be outstanding following the Reverse
Split, especially if the market price of our common stock does not sufficiently increase as a result of the Reverse Split. In addition,
the Reverse Split may decrease the number of stockholders who own round lots (less than 100 shares) of our common stock, creating the
potential for such stockholders to experience an increase in the cost of selling their shares and greater difficulty effecting such sales.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="text-decoration: underline">The increased market price
of our common stock resulting from the Reverse Split may not attract new investors, including institutional investors, and may not satisfy
the investing guidelines of those investors, and consequently, the liquidity of our common stock may not improve</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we believe that a
higher market price may help generate greater or broader investor interest in our common stock, there can be no assurance that the Reverse
Split will result in a per-share price increase sufficient to attract new investors, including institutional investors. Additionally,
there can be no assurance that the market price of our common stock will satisfy the investing guidelines of those investors. As a result,
the trading liquidity of our common stock may not necessarily improve following the Reverse Split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Principal Effects of the Reverse Split</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Reverse Split, if implemented,
will have the following principal effects:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">the number of shares of our common stock held
    by individual stockholders will decrease based on the ratio, and the</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">number of stockholders who own &#8220;round lots&#8221;
    of at least 100 shares of will decrease; and</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">the number of shares of common stock issuable
    upon exercise of outstanding stock options and warrants or conversion</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">of outstanding convertible securities (if any)
    and the exercise price of such outstanding options and warrants and the</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">conversion price of such outstanding convertible
    securities (if any), will be adjusted in accordance with their respective</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">terms based on the ratio at which the Reverse
    Split is effected.</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Shares of common stock after
the Reverse Split will be fully paid and non-assessable. The amendment will not change any of the other terms of our common stock. Following
the Reverse Split, the shares of common stock will have the same voting rights and rights to dividends and distributions and will be identical
in all other respects to the shares of common stock prior to the Reverse Split. Following the Reverse Split, we will continue to be subject
to the reporting requirements of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because the authorized common
stock will not be reduced at the same ratio as the Reverse Split ratio, the Reverse Split will have an overall effect of increasing the
authorized but unissued shares of common stock. These shares may be issued by our Board in its sole discretion. See &#8220;Anti-Takeover
Effects of the Reverse Split&#8221; below. Any future issuance will have the effect of diluting the percentage of stock ownership and
voting rights of the present holders of our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Fractional Shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No fractional shares will
be issued as the result of the Reverse Split. We will round up any fractional shares resulting from the Reverse Split to the nearest whole
share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>No Going Private Transaction</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the decrease
in the number of outstanding shares of common stock following the proposed Reverse Split, our Board does not intend for this transaction
to be the first step in a &#8220;going private transaction&#8221; within the meaning of Rule 13e-3 under the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Procedure for Implementing the Reverse Split</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Reverse Split would become
effective upon the filing with the Secretary of State of New York a Certificate of Amendment to the Certificate of Incorporation as of
the time of filing or such other time set forth in the Certificate of Amendment (the &#8220;Effective Time&#8221;), as determined by our
Board based on its evaluation as to when such action will be the most advantageous to us and our stockholders. Additionally, the Board
reserves the right, notwithstanding stockholder approval and without further action by the stockholders, to elect not to proceed with
the Reverse Split if, at any time prior to the filing of the Certificate of Amendment, the Board, in its sole discretion, determines that
it is no longer in the best interest of the Company and the stockholders to effect the Reverse Split. Beginning at the Effective Time,
each certificate representing shares of common stock will be deemed for all corporate purposes to evidence ownership of the number of
whole shares into which the shares previously represented by the certificate were combined pursuant to the Reverse Split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After the Effective Time,
our Common Stock will have a new Committee on Uniform Securities Identification Procedures (&#8220;CUSIP&#8221;) number, used to identify
our equity securities. Stock certificates with the older CUSIP number will need to be exchanged for stock certificates with the new CUSIP
number by following the procedures described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">Effect on Beneficial Owners of Common Stock</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the implementation of
the Reverse Split, we intend to treat shares held by stockholders through a bank, broker, custodian or other nominee in the same manner
as registered stockholders whose shares are registered in their names with Equity Stock Transfer, the Company&#8217;s transfer agent (the
&#8220;Transfer Agent&#8221;). Banks, brokers, custodians or other nominees will be instructed to effect the Reverse Split for their beneficial
holders holding our common stock in street name. However, these banks, brokers, custodians or other nominees may have different procedures
for processing the Reverse Split. Stockholders who hold our common stock with a bank, broker, custodian or other nominee and who have
any questions in this regard are encouraged to contact their banks, brokers, custodians or other nominees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">Effect on Registered &#8220;Book-Entry&#8221;
Holders of Common Stock</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain registered holders
of our common stock may hold some or all of their shares electronically in book-entry form with the Transfer Agent. These stockholders
do not have stock certificates evidencing their common stock ownership. Such stockholders are, however, provided with a statement reflecting
the number of shares registered in their accounts. Stockholders who hold shares electronically in book-entry form with the Transfer Agent
will not need to take action. The Reverse Split will automatically be reflected in the Transfer Agent&#8217;s records and on their next
statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">Exchange of Stock Certificates</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect that the Transfer
Agent will act as exchange agent for purposes of implementing the exchange of stock certificates for record holders (i.e., stockholders
who hold their shares directly in their own name and not through a broker) in connection with the Reverse Split. As soon as practicable
after the filing of the Certificate of Amendment, registered holders of certificated pre-Reverse Split shares may be asked to surrender
to the Transfer Agent certificates representing pre-Reverse Split shares in exchange for a book entry with the transfer agent or certificates
representing post-Reverse Split shares in accordance with the procedures to be set forth in a letter of transmittal to be sent by us.
No new stock certificates will be issued to a stockholder until such stockholder has surrendered such stockholder&#8217;s outstanding
certificate(s) together with the properly completed and executed letter of transmittal to the Transfer Agent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For street name holders of
pre-Reverse Split shares (i.e., stockholders who hold their shares through a broker), your broker will make the appropriate adjustment
to the number of shares held in your account following the Effective Time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>STOCKHOLDERS SHOULD NOT DESTROY ANY STOCK CERTIFICATE(S)
AND SHOULD NOT SUBMIT ANY CERTIFICATE(S) UNTIL REQUESTED TO DO SO.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Certain Federal Income Tax Consequences</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Each stockholder is advised to consult their
own tax advisor as the following discussion may be limited, modified or not apply based on your particular situation.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following discussion of
the material U.S. federal income tax consequences of the Reverse Split is based on the current provisions of the Internal Revenue Code
of 1986, as amended (the &#8220;Code&#8221;), Treasury regulations promulgated under the Code, Internal Revenue Service (&#8220;IRS&#8221;)
rulings and pronouncements and judicial decisions now in effect. Those legal authorities are subject to change at any time by legislative,
judicial or administrative action, possibly with retroactive effect to the Reverse Split. No ruling from the IRS with respect to the matters
discussed below has been requested, and there is no assurance that the IRS or a court would agree with the conclusions set forth in this
discussion. The following discussion assumes that the pre-split shares of common stock were, and post-split shares will be, held as &#8220;capital
assets&#8221; as defined in the Code. This discussion may not address certain U.S. federal income tax consequences that may be relevant
to particular stockholders in light of their specific circumstances or to certain types of stockholders (like dealers in securities, insurance
companies, foreign individuals and entities, financial institutions and tax-exempt entities) that may be subject to special treatment
under the U.S. federal income tax laws. This discussion also does not address any tax consequences under state, local or foreign laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>PLEASE CONSULT YOUR OWN TAX ADVISOR REGARDING
THE U.S. FEDERAL, STATE, LOCAL, AND FOREIGN INCOME AND OTHER TAX CONSEQUENCES OF THE REVERSE SPLIT IN YOUR PARTICULAR CIRCUMSTANCES UNDER
THE INTERNAL REVENUE CODE AND THE LAWS OF ANY OTHER TAXING JURISDICTION.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will not recognize any gain or loss for U.S.
federal income tax purposes as a result of the Reverse Split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A stockholder will not recognize
gain or loss for U.S. federal income tax purposes on the exchange of pre-Reverse Split shares of our common stock for post-Reverse Split
shares of our common stock in the Reverse Split. A stockholder&#8217;s aggregate tax basis in the post-Reverse Split shares of our common
stock the stockholder receives in the Reverse Split will be the same as the stockholder&#8217;s aggregate tax basis in the pre-Reverse
Split shares of our common stock the stockholder surrenders in exchange therefor. A stockholder&#8217;s holding period for the post-Reverse
Split shares of our common stock the stockholder receives in the Reverse Split will include the stockholder&#8217;s holding period for
the pre-Reverse Split shares of our common stock the stockholder surrenders in exchange therefor. Stockholders who have different bases
or holding periods for pre-Reverse Split shares of our common stock should consult their tax advisors regarding their bases or holding
periods in their post-Reverse Split common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Anti-Takeover Effects of the Reverse Split</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The effective increase in
our authorized and unissued shares of common stock resulting from the Reverse Split could potentially be used by our Board to thwart a
takeover attempt. The overall effects of this might be to discourage, or make it more difficult to engage in, a merger, tender offer or
proxy contest, or the acquisition or assumption of control by a holder of a large block of our securities and the removal of incumbent
management. The Reverse Split could make it more difficult to accomplish a merger or similar transaction, even if such transaction is
beneficial to the stockholders. The Board might use the additional shares to resist or frustrate, by issuing additional shares of common
stock, a third-party takeover effort favored by a majority of the independent stockholders that would provide an above-market premium.
The Reverse Split is not the result of management&#8217;s knowledge of an effort to accumulate the Company&#8217;s securities or to obtain
control of the Company by means of a merger, tender offer, solicitation or otherwise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>The Board recommends a vote &#8220;<span style="text-decoration: underline">FOR</span>&#8221;
this Proposal 3.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="prox10"></span>PROPOSAL 4. ADJOURNMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>General</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is asking its
stockholders to approve, if necessary, a proposal to adjourn the Annual Meeting to a later date and time to solicit additional proxies
in favor of one or more proposals submitted to a vote by the stockholders at the Annual Meeting. Any adjournment of the Annual Meeting
for the purpose of soliciting additional proxies will allow stockholders who have already sent in their proxies to revoke them at any
time prior to the time that the proxies are used.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Vote Required</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The affirmative vote of a
majority of the shares present and entitled to vote is required to approve this Proposal 4. Abstentions will have the same effect as the
vote &#8220;AGAINST&#8221; this Proposal 4.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>The Board recommends a vote &#8220;<span style="text-decoration: underline">FOR</span>&#8221;
this Proposal 4.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="prox11"></span><b>OWNERSHIP OF OUR STOCK</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Voting Securities and Principal Holders Thereof
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the number of shares of our common stock beneficially owned as of the record date by (i) those persons known by us to be owners of more
than 5% of our common stock, (ii) each director, (iii) our Named Executive Officers, and (iv) all of our executive officers and directors
as a group. Unless otherwise specified in the notes to this table, the address for each person is: c/o Forward Industries, Inc., 700 Veterans
Memorial Highway, Suite 100, Hauppauge, New York 11788.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title&#160;of&#160;Class</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Beneficial</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Owner</b></p></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Amount of</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Beneficial</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Ownership (1)</b></p></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Percent</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Beneficially</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Owned (1)</b></p></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td colspan="3" style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Directors and Named Executive Officers:</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock</span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 43%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Terence
    Wise (2)</span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,813,936</span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.7%</span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kathleen Weisberg (3)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0%</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Severino (4)</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,918</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert Wild (5)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,971</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tom KraMer (6)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">168,025</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7%</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharon Hrynkow (7)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107,938</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1%</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sangita Shah (8)</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">484,012</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6%</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James Ziglar (9)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">229,897</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2%</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All directors, nominees
    and executive officers as a group (8 persons) </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,889,697</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.4%</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5% Shareholders:</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Terence Wise (2)</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,813,936</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.7%</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jenny Yu (10) </span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,113,564</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1%</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Renaissance Technologies
    LLC (11)</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">541,140</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">5<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.4%</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">* Less than one percent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="width: 95%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applicable
percentages are based on 10,061,185 shares outstanding as of the record date, adjusted as required by rules of the SEC. Beneficial ownership
is determined under the rules of the SEC and generally includes voting or investment power with respect to securities. Shares of common
stock, underlying options and warrants, and convertible notes currently exercisable or convertible, or exercisable or convertible within
60 days of the record date are deemed outstanding for computing the percentage of the person holding such securities but are not deemed
outstanding for computing the percentage of any other person. Unless otherwise indicated in the footnotes to this table, Forward believes
that each of the shareholders named in the table has sole voting and investment power with respect to the shares of common stock indicated
as beneficially owned by them. The table includes only vested options and warrants or options and warrants that have or will vest and
become exercisable within 60 days of the record date.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="width: 95%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Wise. </b>Mr. Wise is a director and executive officer. Includes 180,395 vested stock options.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="width: 95%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weisberg. </b>Ms. Weisberg is an executive officer.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="width: 95%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Severino</b>. Mr. Severino is an executive officer of one of the Company&#8217;s wholly-owned subsidiaries.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="width: 95%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Wild.</b> Mr. Wild is an executive officer of one of the Company&#8217;s wholly-owned subsidiaries. Includes 22,969 vested stock options.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Kramer</b>. Mr. Kramer is an executive officer of one of the Company&#8217;s wholly-owned subsidiaries.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="width: 95%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Hrynkow. </b>Dr. Hrynkow is a director.&#160;&#160;Includes 93,083 vested stock options.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shah</b>. Ms. Shah is a director. Includes 372,889 vested stock options and 111,123 shares of common stock owned by an entity of which she shares control with her husband.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="width: 95%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ziglar</b>. Mr. Ziglar is a director. Includes 209,897 vested stock options.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
    <td style="width: 95%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Yu. </b>Address
    is 9255 Doheny Rd., Apartment 2905, West Hollywood, California, 90069.</span></td></tr>

<tr style="vertical-align: top">
    <td style="width: 5%; font-size: 10pt">&#160;</td>
    <td style="width: 95%; font-size: 10pt; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-size: 10pt">(11)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><b>Renaissance</b>. Based on Schedule 13G/A filed on February 13, 2023. Address is 800 Third Avenue, New York, New York 10022.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="prox12"></span><b>OTHER MATTERS </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has no knowledge
of any other matters that may come before the Annual Meeting and does not intend to present any other matters. However, if any other matters
shall properly come before the Annual Meeting or any adjournment, the persons soliciting proxies will have the discretion to vote as they
see fit unless directed otherwise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you do not plan to attend
the Annual Meeting, in order that your shares may be represented and in order to assure the required quorum, please sign, date and return
your proxy promptly. In the event you are able to attend the Annual Meeting, at your request, the Company will cancel your previously
submitted proxy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><br />
</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORWARD INDUSTRIES, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD
OF DIRECTORS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ANNUAL MEETING OF SHAREHOLDERS &#8211; FEBRUARY
6, 2024 AT 10:00 A.M.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 15%">&#160;</td>
    <td style="width: 10%">&#160;</td>
    <td style="width: 75%">&#160;</td></tr>
  <tr>
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">VOTING INSTRUCTIONS</span></b></span></td></tr>
  <tr>
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If you vote by phone or internet, please DO NOT mail your proxy card.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="3">&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MAIL:</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please mark, sign, date, and return this Proxy Card promptly using the enclosed envelope.</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PHONE:</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Call 1 (800) 690-6903</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INTERNET:</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">https://www.proxyvote.com</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before the Meeting &#8211; Go to www.proxyvote.com.  Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time on February 5, 2024. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. <br />
<br />
</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Control ID:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Proxy ID:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Password:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 100%">&#160;</td></tr>
  <tr>
    <td style="border-top: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MARK &#8220;X&#8221; HERE IF YOU PLAN TO ATTEND THE MEETING: </b></span><b><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></b></td></tr>
  <tr>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MARK HERE FOR ADDRESS CHANGE &#168;&#160;New Address
    (if applicable):</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">____________________________</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">____________________________</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">____________________________</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>IMPORTANT: </b>Please sign exactly as your name or names appear
    on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian,
    please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full
    title as such. If signer is a partnership, please sign in partnership name by authorized person.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: ________________________, 202___</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print Name of Shareholder and/or Joint Tenant)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature of Shareholder)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Second Signature if held jointly)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The shareholder(s) hereby appoints <b>Terence
Wise</b> and <b>Kathleen Weisberg</b>, or either of them, as proxies, each with the power to appoint his substitute, and hereby authorizes
them to represent and to vote, as designated on the reverse side of this ballot, all of the shares of voting stock of FORWARD INDUSTRIES,
INC. that the shareholder(s) is/are entitled to vote at the Annual Meeting of Shareholder(s) to be held at 10:00 a.m., New York time on
February 6, 2024, at 1301 Avenue of the Americas, Seventh Floor, in New York, New York, and any adjournment or postponement thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 37 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>This proxy, when properly executed, will be
voted in the manner directed herein. If no such direction is made, this proxy will be voted &#8220;FOR&#8221; all of the nominees in
Proposal 1 and &#8220;FOR&#8221; Proposal 2 and Proposal 3 and Proposal 4. If any other business is presented at the meeting, this proxy
will be voted by the above-named proxies at the direction of the Board of Directors. At the present time, the Board of Directors knows
of no other business to be presented at the meeting.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Proposal</b>:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1. To elect members to Forward&#8217;s Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Terence Wise</span></td>
    <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR </span><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td style="width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WITHHOLD </span><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sangita Shah</span></td>
    <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR </span><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WITHHOLD </span><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharon Hrynkow</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR </span><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WITHHOLD </span><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. To ratify and approve the appointment of Forward&#8217;s independent registered public accounting firm for fiscal 2024.</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR </span><span style="font-family: Wingdings; font-size: 10pt">&#168;</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;AGAINST </span><span style="font-family: Wingdings; font-size: 10pt">&#168;</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;ABSTAIN </span><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="4">&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. To approve an amendment to our Certificate of Incorporation, at the discretion of the board of directors, to effect a reverse stock split of our issued and outstanding shares of common stock, at a specific ratio, ranging from one-for-two (1:2) to one-for-three (1:3).</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR </span><span style="font-family: Wingdings; font-size: 10pt">&#168;</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;AGAINST </span><span style="font-family: Wingdings; font-size: 10pt">&#168;</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;ABSTAIN </span><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="4">&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. The approval of one or more adjournments of the Annual Meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve any of the proposals presented for a vote at the Annual Meeting.</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR </span><span style="font-family: Wingdings; font-size: 10pt">&#168;</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;AGAINST </span><span style="font-family: Wingdings; font-size: 10pt">&#168;</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;ABSTAIN </span><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="4">&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="4">&#160;</td>
    <td colspan="2">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Control ID:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Proxy ID:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Password:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b><span style="text-decoration: underline">Annex A</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CERTIFICATE OF AMENDMENT </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OF THE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CERTIFICATE OF INCORPORATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OF </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORWARD INDUSTRIES, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Under Section 805 of the Business Corporation Law</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FIRST: The current name of the corporation is:
Forward Industries, Inc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SECOND: The date of filing of the certificate
of incorporation with the Department of State is: ___________________.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THIRD: The amendment effected by this certificate
of amendment is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Paragraph THIRD of the Certificate of Incorporation
relating to the number of shares of stock of the Company is amended to read in its entirety as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The aggregate number of shares
which the Corporation shall have authority to issue is forty four million (44,000,000), $.01 par value per share, of which four million
(4,000,000) shall be designated as &#8220;preferred stock&#8221; and forty million (40,000,000) shall be designated &#8220;common stock&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Authority is hereby expressly
granted to the Board of Directors of the Corporation from time to time to issue the preferred stock as preferred stock of any series
and, in connection with the creation of each such series, to fix by the resolution or resolutions providing for the issue of shares thereof,
the number of shares of such series, and the designations, relative rights, preferences, and limitations of such series, to the full
extent now or hereafter permitted by the laws of the State of New York.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the close of business
on [DATE] (4:01 p.m. Eastern Daylight Time) (the &#8220;Reverse Split Date&#8221;), each [number] shares of common stock issued and outstanding
immediately prior to the Reverse Split Date (referred to in this paragraph as the &#8220;Old Common Stock&#8221;) automatically and without
any action on the part of the holder thereof will be reclassified and changed into [number] share of new common stock, par value $.01
per share (referred to in this paragraph as the &#8220;New Common Stock&#8221;), subject to the treatment of fractional share interests
as described below. Each holder of a certificate or certificates that immediately prior to the Reverse Split Date represented outstanding
shares of Old Common Stock (the &#8216;&#8216;Old Certificates&#8217;&#8217;) will be entitled to receive, upon surrender of such Old
Certificates to the Company for cancellation, a certificate or certificates (the &#8216;&#8216;New Certificate&#8217;&#8217;, whether
one or more) representing the number of whole shares of the New Common Stock into which and for which the shares of the Old Common Stock
formerly represented by such Old Certificates so surrendered are reclassified under the terms hereof. From and after the Reverse Split
Date, Old Certificates shall represent only the right to receive New Certificates pursuant to the provisions hereof. Any fraction of
a share of Common Stock that would otherwise have resulted from the foregoing combination shall be rounded up to the nearest whole share
of Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If more than one Old Certificate
shall be surrendered at one time for the account of the same shareholder, the number of full shares of New Common Stock for which New
Certificates shall be issued shall be computed on the basis of the aggregate number of shares represented by the Old Certificates so surrendered.
In the event that the Company determines that a holder of Old Certificates has not tendered all his, her or its certificates for exchange,
the Company shall carry forward any fractional share until all certificates of that holder have been presented for exchange. The Old Certificates
surrendered for exchange shall be properly endorsed and otherwise in proper form for transfer. From and after the Reverse Split Date,
the amount of capital represented by the shares of the New Common Stock into which and for which the shares of the Old Common Stock are
reclassified under the terms hereof shall be an amount equal to the product of the number of issued and outstanding shares of New Common
Stock and the $0.01 par value of each such share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOURTH: The certificate of amendment was authorized
by:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The vote of the board of directors followed by
a vote of a majority of all outstanding shares entitled to vote thereon at a meeting of shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 23%"><b>X</b></td>
    <td style="width: 2%">&#160;</td>
  <td style="width: 23%">&#160;</td>
  <td style="width: 52%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-top: Black 1pt solid">&#160;</td>
    <td>&#160;</td>
  <td style="border-top: Black 1pt solid">(Name of Signer)</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
    <td>&#160;</td>
  <td style="border-top: Black 1pt solid">(Title of Signer)</td>
  <td>&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 39; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  U $ # 2(  A$! Q$!_\0
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M)!(/V.3D?[IKS1]"\%Z1H&@7&I:9J%S=ZE:K(%M69B6"J6.-P_O=J]+\:?\
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9ZO \46TJ<@8Z].!Q[444*E"^Q+J2MN?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  K #D# 2(  A$! Q$!_\0
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M=^6,4W_6YY[?>%(-4T^^UG1K"6PT6SB9XYKAV:2Z(_N@]![_ ,^@Y+[9=?\
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M_P"8V^M^1]69]*QO$/AZP\2Z8UG?+T^:*5?OQ-V93_G-?-G]M:K_ -!2^_\
M A_\:/[:U7_H*7W_ ($/_C3^I2B[J0OK::LXGJ.K>(-0TGP[JOACQ,2UR;5Q
M97V/ENE'0$_WO\GGD^1U)-?WEZ52[NYYU5L@2R%L?G73?V/8?\\/_'V_QKMI
)TE!').HY,__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  R #,# 2(  A$! Q$!_\0
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..CUVBBBO"/9"BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  U $ # 2(  A$! Q$!_\0
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BUR_TQKA;6.2RG5X'BBVE3D<=>G X]J**%2A?83G*VY__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>ford-20230930.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOa+CyaPty5526YkxvmR6fQmqLykqmmIPdi8ITQkmcYgL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:FORD="http://forwardindustries.com/20230930" elementFormDefault="qualified" targetNamespace="http://forwardindustries.com/20230930">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://forwardindustries.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="ford-20230930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ford-20230930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ford-20230930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="FORD_AdjustmentType1Member" name="AdjustmentType1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FORD_AdjustmentType2Member" name="AdjustmentType2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FORD_AdjustmentType3Member" name="AdjustmentType3Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FORD_AdjustmentType4Member" name="AdjustmentType4Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FORD_AdjustmentType5Member" name="AdjustmentType5Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FORD_AdjustmentType6Member" name="AdjustmentType6Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FORD_AdjustmentType7Member" name="AdjustmentType7Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>ford-20230930_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://forwardindustries.com/role/Cover" xlink:href="ford-20230930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosureWithAdditionalMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpTable" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpAdjustmentsToCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#TabularListsByExecutiveCategory" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#TabularListMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpExecutiveCategoriesOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpAdjustmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#IndividualsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#TradingArrangmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ForgoneRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#OutstandingRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardsCloseToMnpiDisc" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangemenstByInd" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/Defaults" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#Defaults" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://forwardindustries.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType1Member" xlink:label="loc_FORDAdjustmentType1Member" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_FORDAdjustmentType1Member" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType2Member" xlink:label="loc_FORDAdjustmentType2Member" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_FORDAdjustmentType2Member" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType3Member" xlink:label="loc_FORDAdjustmentType3Member" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_FORDAdjustmentType3Member" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType4Member" xlink:label="loc_FORDAdjustmentType4Member" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_FORDAdjustmentType4Member" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType5Member" xlink:label="loc_FORDAdjustmentType5Member" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_FORDAdjustmentType5Member" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType6Member" xlink:label="loc_FORDAdjustmentType6Member" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_FORDAdjustmentType6Member" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType7Member" xlink:label="loc_FORDAdjustmentType7Member" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_FORDAdjustmentType7Member" xlink:type="arc" order="60" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>ford-20230930_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis" xlink:label="ecd_ExecutiveCategoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ExecutiveCategoryAxis" xlink:to="ecd_ExecutiveCategoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ExecutiveCategoryAxis_lbl" xml:lang="en-US">Executive Category [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember" xlink:label="ecd_PeoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoMember" xlink:to="ecd_PeoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoMember_lbl" xml:lang="en-US">PEO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType1Member" xlink:label="FORD_AdjustmentType1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FORD_AdjustmentType1Member" xlink:to="FORD_AdjustmentType1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FORD_AdjustmentType1Member_lbl" xml:lang="en-US">Deduct "Stock Awards" and "Option Awards" Reported in Summary Compensation Table [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType2Member" xlink:label="FORD_AdjustmentType2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FORD_AdjustmentType2Member" xlink:to="FORD_AdjustmentType2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FORD_AdjustmentType2Member_lbl" xml:lang="en-US">Add Year-End Fair Value of Outstanding and Unvested Equity Awards Granted in the Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType3Member" xlink:label="FORD_AdjustmentType3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FORD_AdjustmentType3Member" xlink:to="FORD_AdjustmentType3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FORD_AdjustmentType3Member_lbl" xml:lang="en-US">Add (Deduct) Year Over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType4Member" xlink:label="FORD_AdjustmentType4Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FORD_AdjustmentType4Member" xlink:to="FORD_AdjustmentType4Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FORD_AdjustmentType4Member_lbl" xml:lang="en-US">Add Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType5Member" xlink:label="FORD_AdjustmentType5Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FORD_AdjustmentType5Member" xlink:to="FORD_AdjustmentType5Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FORD_AdjustmentType5Member_lbl" xml:lang="en-US">Add (Deduct) Year Over Year Change in Fair Value of Equity Awards Granted in Prior Years Which Vested in the Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType6Member" xlink:label="FORD_AdjustmentType6Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FORD_AdjustmentType6Member" xlink:to="FORD_AdjustmentType6Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FORD_AdjustmentType6Member_lbl" xml:lang="en-US">Add Value of any Dividends or Other Earnings Paid in the Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType7Member" xlink:label="FORD_AdjustmentType7Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FORD_AdjustmentType7Member" xlink:to="FORD_AdjustmentType7Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FORD_AdjustmentType7Member_lbl" xml:lang="en-US">Compensation Actually Paid [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember" xlink:label="ecd_NonPeoNeoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoMember" xlink:to="ecd_NonPeoNeoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoMember_lbl" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Summary Comp.Table Total for CEO</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="ecd_AwardsCloseToMnpiDiscTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTable" xlink:to="ecd_AwardsCloseToMnpiDiscTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Award Underlying Securities Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Award Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Award Grant Date Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable" xlink:label="ecd_TradingArrByIndTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrByIndTable" xlink:to="ecd_TradingArrByIndTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrByIndTable_lbl" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis" xlink:label="ecd_TradingArrAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrAxis" xlink:to="ecd_TradingArrAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrAxis_lbl" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="ecd_TrdArrSecuritiesAggAvailAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt_lbl" xml:lang="en-US">Aggregate Available</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>ford-20230930_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://forwardindustries.com/role/Cover" xlink:href="ford-20230930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://forwardindustries.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis" xlink:label="loc_ecdExecutiveCategoryAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdExecutiveCategoryAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember" xlink:label="loc_ecdAllExecutiveCategoriesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdExecutiveCategoryAxis" xlink:to="loc_ecdAllExecutiveCategoriesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember" xlink:label="loc_ecdPeoMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllExecutiveCategoriesMember" xlink:to="loc_ecdPeoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember" xlink:label="loc_ecdNonPeoNeoMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllExecutiveCategoriesMember" xlink:to="loc_ecdNonPeoNeoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType1Member" xlink:label="loc_FORDAdjustmentType1Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_FORDAdjustmentType1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType2Member" xlink:label="loc_FORDAdjustmentType2Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_FORDAdjustmentType2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType3Member" xlink:label="loc_FORDAdjustmentType3Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_FORDAdjustmentType3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType4Member" xlink:label="loc_FORDAdjustmentType4Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_FORDAdjustmentType4Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType5Member" xlink:label="loc_FORDAdjustmentType5Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_FORDAdjustmentType5Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType6Member" xlink:label="loc_FORDAdjustmentType6Member" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_FORDAdjustmentType6Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ford-20230930.xsd#FORD_AdjustmentType7Member" xlink:label="loc_FORDAdjustmentType7Member" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_FORDAdjustmentType7Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="loc_ecdAwardsCloseToMnpiDiscTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable" xlink:label="loc_ecdTradingArrByIndTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTradingArrByIndTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis" xlink:label="loc_ecdTradingArrAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdTradingArrAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember" xlink:label="loc_ecdAllTradingArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrAxis" xlink:to="loc_ecdAllTradingArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="loc_ecdTrdArrSecuritiesAggAvailAmt" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrSecuritiesAggAvailAmt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140628738440976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FORWARD
INDUSTRIES, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000038264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140628736434960">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_880_eecd--PvpTableTextBlock_zCwHOOMYSrs3" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year <br/>
(a)</span></td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary Compensation Table Total for PEO<br/>
(b)(1)($)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation Actually Paid to PEO<br/>
(c)(2)</span>($)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average Summary Compensation Table Total for non-PEO Named Executive Officers<br/>
(d)(3)($)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average Compensation Actually Paid to non-PEO Named Executive Officers<br/>
(e)(2)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Value of Initial Fixed $100 Investment Based On Total Shareholder Return<br/>
(f)(4)($)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Income<br/>
(g)(5)($)</span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td>&#160;</td>
    <td colspan="2" id="xdx_98B_eecd--PeoTotalCompAmt_c20221001__20230930_fKDEp_zqQtPe4psy2j" style="text-align: center" title="PEO Total Compensation Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">337,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" id="xdx_98A_eecd--PeoActuallyPaidCompAmt_c20221001__20230930_fKDIp_zak8EVFFOrHg" style="text-align: center" title="PEO Actually Paid Compensation Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">337,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" id="xdx_986_eecd--NonPeoNeoAvgTotalCompAmt_c20221001__20230930_fKDMp_zs00p4juSeBc" style="text-align: center" title="Non-PEO NEO Average Total Compensation Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">304,945</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" id="xdx_983_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20221001__20230930_fKDIp_zGR7OdOH0Eve" style="text-align: center" title="Non-PEO NEO Average Compensation Actually Paid Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">302,996</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" id="xdx_98B_eecd--TotalShareholderRtnAmt_c20221001__20230930_fKDQp_zEgLrCi73ZL5" style="text-align: center" title="Total Shareholder Return Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" id="xdx_98B_eus-gaap--NetIncomeLoss_c20221001__20230930_fKDUp_zbyR4Q7I4o42" style="text-align: center" title="Net Income (Loss)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,716,651)</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_985_eecd--PeoTotalCompAmt_c20211001__20220930_fKDEp_zunmKWQV7Pzl" style="text-align: center" title="PEO Total Compensation Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">330,750</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_987_eecd--PeoActuallyPaidCompAmt_c20211001__20220930_fKDIp_zzhj47NX7Aq6" style="text-align: center" title="PEO Actually Paid Compensation Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">330,750</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_980_eecd--NonPeoNeoAvgTotalCompAmt_c20211001__20220930_fKDMp_znuzy8V7WhOh" style="text-align: center" title="Non-PEO NEO Average Total Compensation Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">286,498</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_98E_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20211001__20220930_fKDIp_zQng5PCRwyy6" style="text-align: center" title="Non-PEO NEO Average Compensation Actually Paid Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">285,882</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_988_eecd--TotalShareholderRtnAmt_c20211001__20220930_fKDQp_zNaUE6CtAjke" style="text-align: center" title="Total Shareholder Return Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_98C_eus-gaap--NetIncomeLoss_c20211001__20220930_fKDUp_zT66EFcc0EVf" style="text-align: center" title="Net Income (Loss)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,378,251)</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 16%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 11%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 11%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 11%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 11%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 11%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 11%">&#160;</td>
    <td style="width: 1%">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_840_eecd--NamedExecutiveOfficersFnTextBlock_dU_zsrz1b8uRI97" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">______________</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span id="xdx_F05_z93jD5QSLc18" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify; width: 96%"><span id="xdx_F1F_zewWtGFk7Ote" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents the amounts reported for <span id="xdx_908_eecd--PeoName_c20221001__20230930_zfxhn2CRcaT"><span id="xdx_90F_eecd--PeoName_c20211001__20220930_zcxEelDByyNl">Mr. Wise</span></span> (the &#8220;PEO&#8221;) in the &#8220;Total&#8221; column of the &#8220;Summary Compensation Table&#8221; in each applicable year. </span></td></tr>
</table>

<p style="margin: 0">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span id="xdx_F04_zo5HwSt4c0E6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td id="xdx_F1C_ziVjTiN5dNyg" style="text-align: justify; width: 96%">SEC rules require certain adjustments be made to the &#8220;Summary Compensation Table&#8221; totals to determine &#8220;compensation actually paid&#8221; as reported in the &#8220;Pay Versus Performance&#8221; table above. For purposes of the equity award adjustments shown below, no equity awards were cancelled as a result of a failure to meet vesting conditions. The valuation assumptions used to calculate fair values for purposes of the compensation actually paid calculation did not materially differ from those disclosed at the time of grant (as applicable). The following table details the applicable adjustments to the amount in the &#8220;Total&#8221; column of the &#8220;Summary Compensation Table&#8221; in each applicable year that were made to determine &#8220;compensation actually paid&#8221; (all amounts are averages for the NEOs other than the PEO):</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>



<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="display: none; margin-top: 0; margin-bottom: 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; display: none; text-align: center"></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; display: none; width: 100%"><tr style="display: none; vertical-align: top"><td style="display: none; width: 4%"><span id="xdx_F02_zpnafTwdXRLe" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt">(3)</span></td>
    <td style="display: none; text-align: justify; width: 96%"><span id="xdx_F1B_zYYlWZfqUa2l" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt">Represents the average of the amounts reported for the named executive officers (NEOs) as a group (excluding the PEO) in the &#8220;Total&#8221; column of the &#8220;Summary Compensation Table&#8221; in each applicable year. The names of each of the NEOs included for these purposes for 2023 and 2022 are Anthony Camarda, Robert Wild, Paul Severino and Tom KraMer.</span></td></tr>
</table>

<p style="margin: 0; display: none">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; display: none; width: 100%">
  <tr style="display: none; vertical-align: top">
    <td style="display: none; width: 4%"><span id="xdx_F01_zkujJW59oU0h" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt">(4)</span></td>
    <td style="display: none; text-align: justify; width: 96%"><span id="xdx_F18_zgxRZ7ecv2mg" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt">Represents the cumulative total shareholder return of a fixed investment of $100 made at the closing price of the Company&#8217;s common stock at September 30, 2021 for the measurement period beginning on such date and continuing through and including the end of the applicable fiscal year reflected in the table.</span></td></tr>
</table>

<p style="margin: 0; display: none">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; display: none; width: 100%">
  <tr style="display: none; vertical-align: top">
    <td style="display: none; width: 4%"><span id="xdx_F08_zYsOItQPIN4i" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt">(5)</span></td>
    <td style="display: none; text-align: justify; width: 96%"><span id="xdx_F1F_zkzAv4TKssd4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt">Represents the amount of net loss reflected in the Company&#8217;s audited financial statements for the applicable fiscal year reflected in the table.</span></td></tr></table>


<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 337,000<span></span>
</td>
<td class="nump">$ 330,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 337,000<span></span>
</td>
<td class="nump">330,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_847_eecd--AdjToPeoCompFnTextBlock_dU_zytiXv6xtgp" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Year</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Name</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Summary</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Compensation</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Table Total</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Deduct
                                            &#8220;Stock</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Awards&#8221;
    and</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>&#8220;Option</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Awards&#8221;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>reported in</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Summary</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Compensation</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Table</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Add
                                            Year-</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>End Fair</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Value of</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Outstanding</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>and</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Unvested</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Equity</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Awards</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Granted in</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>the Year</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Add
                                            (Deduct)</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Year over</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Year Change</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>in Fair</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Value of</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Outstanding</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>and Unvested</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Equity</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Awards</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Granted in</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Prior Years</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Add
                                            Fair</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Value as of</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Vesting Date</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>of Equity</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Awards</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Granted and</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Vested in</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>the Year</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Add</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>(Deduct)</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Year over</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Year Change</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>in Fair Value</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>of Equity</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Awards</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Granted in</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Prior Years</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>which</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Vested in</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>the Year</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Add
                                            Value</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>of any</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Dividends</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>or Other</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Earnings</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Paid in</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>the Year</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Compensation</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Actually Paid</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>($)</b></span></p></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 19%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">PEO</span></td>
    <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_986_eecd--PeoTotalCompAmt_c20221001__20230930_zAFWFGEd81nh" style="width: 6%; text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">337,000</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_98D_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType1Member_zaIYdNAytuQg" style="width: 6%; text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType2Member_zQxLOZU7iwA1" style="width: 6%; text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_98A_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType3Member_zfRvvYaME3o2" style="width: 6%; text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_98C_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType4Member_zBFcxB2Cpvnj" style="width: 6%; text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_98A_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType5Member_zmjH0KoiKOmg" style="width: 6%; text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType6Member_z20frLH60Nfi" style="width: 6%; text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_987_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType7Member_zd9xbeQk8rA8" style="width: 6%; text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">337,000</span></td>
    <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other NEOs</span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_989_eecd--NonPeoNeoAvgTotalCompAmt_c20221001__20230930_zBsKPOAEoe3l" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">304,945</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_983_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType1Member_z6AdaeUPiUz4" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_982_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType2Member_zeduNCByvMza" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_981_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType3Member_zG29AeK9Zx0i" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,210)</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_987_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType4Member_zngEMF1uAVb" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType5Member_zkN6p0Vwi1Ub" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(739)</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_986_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType6Member_zzURSu7JyNQl" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_983_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType7Member_zQcIbIReSbQ6" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">302,996</span></td>
    <td><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">PEO</span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_982_eecd--PeoTotalCompAmt_c20211001__20220930_zhQzzGhso179" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">330,750</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_985_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType1Member_zIrAyk4ET7ul" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_982_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType2Member_zGSuWM8te49a" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_988_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType3Member_zpWdWuPpMutb" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_989_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType4Member_zkf2SssUjsJ9" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_98B_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType5Member_zEIr9iRChxVg" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_980_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType6Member_zogKSv7PJr77" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_982_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType7Member_zFUCpOncRCv2" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">330,750</span></td>
    <td><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other NEOs</span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_982_eecd--NonPeoNeoAvgTotalCompAmt_c20211001__20220930_zbQSHayqaVpf" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">286,498</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_98D_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType1Member_zjmIjnqyT9Pi" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,000</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_987_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType2Member_zLhJ4JMQwWgh" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,717</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_988_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType3Member_zxkCJlrwaJZf" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_988_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType4Member_zAZhVmwtIPwa" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,667</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_98C_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType5Member_zIQzDjqxqpF4" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_988_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType6Member_z5UUG8KOJYec" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td id="xdx_982_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType7Member_zn6BFSJmDmni" style="text-align: center" title="Summary Comp.Table Total for CEO"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">285,882</span></td>
    <td><span style="font-size: 9pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 9pt">________________</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3)</span></td>
    <td style="text-align: justify; width: 96%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Represents the average of the amounts reported for the named executive officers (NEOs) as a group (excluding the PEO) in the &#8220;Total&#8221; column of the &#8220;Summary Compensation Table&#8221; in each applicable year. The names of each of the NEOs included for these purposes for 2023 and 2022 are Anthony Camarda, Robert Wild, Paul Severino and Tom Kramer.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Represents the cumulative total shareholder return of a fixed investment of $100 made at the closing price of the Company&#8217;s common stock at September 30, 2021 for the measurement period beginning on such date and continuing through and including the end of the applicable fiscal year reflected in the table.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Represents the amount of net loss reflected in the Company&#8217;s audited financial statements for the applicable fiscal year reflected in the table.</span></td></tr>
  </table>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">$ 304,945<span></span>
</td>
<td class="nump">286,498<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 302,996<span></span>
</td>
<td class="nump">285,882<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_89A_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zlsifGlJe078" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Relationship Between Compensation Actually
Paid and our Total Shareholder Return</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our stock price performance
is not one of the elements used in determining Compensation Actually Paid to our Named Executive Officers. However, the amount of Compensation
Actually Paid to our Named Executive Officers aligns with the Company&#8217;s Total Shareholder Return (TSR) due to the fact that a portion
of the compensation paid to our Named Executive Officers is comprised of equity awards. In both 2023 and 2022, the amount of Compensation
Actually Paid to our Named Executive Officers was less than the Summary Compensation Table total for the Named Executive Officers due
to the decline in fair value of equity awards due in part to the declining stock price and TSR.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_897_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zu5kxKqi3YEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Relationship Between Compensation Actually
Paid and our Net Income (Loss)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">GAAP net income (loss) is a measure of our overall profitability that
we believe is a factor that can drive our stock price performance. However, Compensation Actually Paid is less sensitive to our annual
GAAP income (loss) because management and our Board does not believe that our GAAP income (loss) is the only meaningful measure in allowing
investors to evaluate management&#8217;s performance, primarily due to: (i) losses incurred by our now discontinued retail segment which
the Board believes was as a result of supply chain issues and the pandemic which were outside of the control of our NEOs and (ii) the
need to retain key executives with the skills to provide the leadership the Company needs to succeed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="num">$ (3,716,651)<span></span>
</td>
<td class="num">$ (1,378,251)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Mr. Wise<span></span>
</td>
<td class="text">Mr. Wise<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Deduct "Stock Awards" and "Option Awards" Reported in Summary Compensation Table [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Add Year-End Fair Value of Outstanding and Unvested Equity Awards Granted in the Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Add (Deduct) Year Over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Add Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Add (Deduct) Year Over Year Change in Fair Value of Equity Awards Granted in Prior Years Which Vested in the Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Add Value of any Dividends or Other Earnings Paid in the Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Compensation Actually Paid [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">337,000<span></span>
</td>
<td class="nump">330,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Deduct "Stock Awards" and "Option Awards" Reported in Summary Compensation Table [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Add Year-End Fair Value of Outstanding and Unvested Equity Awards Granted in the Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,717<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Add (Deduct) Year Over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,210)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Add Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Add (Deduct) Year Over Year Change in Fair Value of Equity Awards Granted in Prior Years Which Vested in the Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(739)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Add Value of any Dividends or Other Earnings Paid in the Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Compensation Actually Paid [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 302,996<span></span>
</td>
<td class="nump">$ 285,882<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents the amounts reported for <span id="xdx_908_eecd--PeoName_c20221001__20230930_zfxhn2CRcaT"><span id="xdx_90F_eecd--PeoName_c20211001__20220930_zcxEelDByyNl">Mr. Wise</span></span> (the &#8220;PEO&#8221;) in the &#8220;Total&#8221; column of the &#8220;Summary Compensation Table&#8221; in each applicable year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">SEC rules require certain adjustments be made to the &#8220;Summary Compensation Table&#8221; totals to determine &#8220;compensation actually paid&#8221; as reported in the &#8220;Pay Versus Performance&#8221; table above. For purposes of the equity award adjustments shown below, no equity awards were cancelled as a result of a failure to meet vesting conditions. The valuation assumptions used to calculate fair values for purposes of the compensation actually paid calculation did not materially differ from those disclosed at the time of grant (as applicable). The following table details the applicable adjustments to the amount in the &#8220;Total&#8221; column of the &#8220;Summary Compensation Table&#8221; in each applicable year that were made to determine &#8220;compensation actually paid&#8221; (all amounts are averages for the NEOs other than the PEO):</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Represents the average of the amounts reported for the named executive officers (NEOs) as a group (excluding the PEO) in the &#8220;Total&#8221; column of the &#8220;Summary Compensation Table&#8221; in each applicable year. The names of each of the NEOs included for these purposes for 2023 and 2022 are Anthony Camarda, Robert Wild, Paul Severino and Tom KraMer.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Represents the cumulative total shareholder return of a fixed investment of $100 made at the closing price of the Company&#8217;s common stock at September 30, 2021 for the measurement period beginning on such date and continuing through and including the end of the applicable fiscal year reflected in the table.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Represents the amount of net loss reflected in the Company&#8217;s audited financial statements for the applicable fiscal year reflected in the table.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=FORD_AdjustmentType1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=FORD_AdjustmentType1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=FORD_AdjustmentType2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=FORD_AdjustmentType2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=FORD_AdjustmentType3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=FORD_AdjustmentType3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=FORD_AdjustmentType4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=FORD_AdjustmentType4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=FORD_AdjustmentType5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=FORD_AdjustmentType5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=FORD_AdjustmentType6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=FORD_AdjustmentType6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=FORD_AdjustmentType7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=FORD_AdjustmentType7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>forward_def14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:FORD="http://forwardindustries.com/20230930"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ford-20230930.xsd" xlink:type="simple"/>
    <context id="From2022-10-01to2023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2021-10-012022-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType5Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType7Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType5Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType7Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType5Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType7Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType5Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType7Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">FORD:AdjustmentType7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2022-10-01to2023-09-30">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2022-10-01to2023-09-30">0000038264</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2022-10-01to2023-09-30" id="xdx2ixbrl0010">DEF 14A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2022-10-01to2023-09-30">FORWARD INDUSTRIES, INC.</dei:EntityRegistrantName>
    <ecd:PvpTableTextBlock contextRef="From2022-10-01to2023-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_880_eecd--PvpTableTextBlock_zCwHOOMYSrs3" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Year &lt;br/&gt;
(a)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Summary Compensation Table Total for PEO&lt;br/&gt;
(b)(1)($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Compensation Actually Paid to PEO&lt;br/&gt;
(c)(2)&lt;/span&gt;($)&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average Summary Compensation Table Total for non-PEO Named Executive Officers&lt;br/&gt;
(d)(3)($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average Compensation Actually Paid to non-PEO Named Executive Officers&lt;br/&gt;
(e)(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Value of Initial Fixed $100 Investment Based On Total Shareholder Return&lt;br/&gt;
(f)(4)($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net Income&lt;br/&gt;
(g)(5)($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_98B_eecd--PeoTotalCompAmt_c20221001__20230930_fKDEp_zqQtPe4psy2j" style="text-align: center" title="PEO Total Compensation Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;337,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_98A_eecd--PeoActuallyPaidCompAmt_c20221001__20230930_fKDIp_zak8EVFFOrHg" style="text-align: center" title="PEO Actually Paid Compensation Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;337,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_986_eecd--NonPeoNeoAvgTotalCompAmt_c20221001__20230930_fKDMp_zs00p4juSeBc" style="text-align: center" title="Non-PEO NEO Average Total Compensation Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;304,945&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_983_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20221001__20230930_fKDIp_zGR7OdOH0Eve" style="text-align: center" title="Non-PEO NEO Average Compensation Actually Paid Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;302,996&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_98B_eecd--TotalShareholderRtnAmt_c20221001__20230930_fKDQp_zEgLrCi73ZL5" style="text-align: center" title="Total Shareholder Return Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;32&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_98B_eus-gaap--NetIncomeLoss_c20221001__20230930_fKDUp_zbyR4Q7I4o42" style="text-align: center" title="Net Income (Loss)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,716,651)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_985_eecd--PeoTotalCompAmt_c20211001__20220930_fKDEp_zunmKWQV7Pzl" style="text-align: center" title="PEO Total Compensation Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;330,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_987_eecd--PeoActuallyPaidCompAmt_c20211001__20220930_fKDIp_zzhj47NX7Aq6" style="text-align: center" title="PEO Actually Paid Compensation Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;330,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_980_eecd--NonPeoNeoAvgTotalCompAmt_c20211001__20220930_fKDMp_znuzy8V7WhOh" style="text-align: center" title="Non-PEO NEO Average Total Compensation Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;286,498&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_98E_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20211001__20220930_fKDIp_zQng5PCRwyy6" style="text-align: center" title="Non-PEO NEO Average Compensation Actually Paid Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;285,882&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_988_eecd--TotalShareholderRtnAmt_c20211001__20220930_fKDQp_zNaUE6CtAjke" style="text-align: center" title="Total Shareholder Return Amount"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;56&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_98C_eus-gaap--NetIncomeLoss_c20211001__20220930_fKDUp_zT66EFcc0EVf" style="text-align: center" title="Net Income (Loss)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,378,251)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 16%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 11%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 11%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 11%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 11%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 11%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 11%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-10-01to2023-09-30"
      decimals="0"
      id="Fact000015"
      unitRef="USD">337000</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2022-10-01to2023-09-30"
      decimals="0"
      id="Fact000017"
      unitRef="USD">337000</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2022-10-01to2023-09-30"
      decimals="0"
      id="Fact000019"
      unitRef="USD">304945</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2022-10-01to2023-09-30"
      decimals="0"
      id="Fact000021"
      unitRef="USD">302996</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2022-10-01to2023-09-30"
      decimals="0"
      id="Fact000023"
      unitRef="USD">32</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-10-01to2023-09-30"
      decimals="0"
      id="Fact000025"
      unitRef="USD">-3716651</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="From2021-10-012022-09-30"
      decimals="0"
      id="Fact000027"
      unitRef="USD">330750</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2021-10-012022-09-30"
      decimals="0"
      id="Fact000029"
      unitRef="USD">330750</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2021-10-012022-09-30"
      decimals="0"
      id="Fact000031"
      unitRef="USD">286498</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2021-10-012022-09-30"
      decimals="0"
      id="Fact000033"
      unitRef="USD">285882</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2021-10-012022-09-30"
      decimals="0"
      id="Fact000035"
      unitRef="USD">56</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-10-012022-09-30"
      decimals="0"
      id="Fact000037"
      unitRef="USD">-1378251</us-gaap:NetIncomeLoss>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="From2022-10-01to2023-09-30">&lt;p id="xdx_840_eecd--NamedExecutiveOfficersFnTextBlock_dU_zsrz1b8uRI97" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;______________&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 4%"&gt;&lt;span id="xdx_F05_z93jD5QSLc18" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 96%"&gt;&lt;span id="xdx_F1F_zewWtGFk7Ote" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents the amounts reported for &lt;span id="xdx_908_eecd--PeoName_c20221001__20230930_zfxhn2CRcaT"&gt;&lt;span id="xdx_90F_eecd--PeoName_c20211001__20220930_zcxEelDByyNl"&gt;Mr. Wise&lt;/span&gt;&lt;/span&gt; (the &#x201c;PEO&#x201d;) in the &#x201c;Total&#x201d; column of the &#x201c;Summary Compensation Table&#x201d; in each applicable year. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 4%"&gt;&lt;span id="xdx_F04_zo5HwSt4c0E6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1C_ziVjTiN5dNyg" style="text-align: justify; width: 96%"&gt;SEC rules require certain adjustments be made to the &#x201c;Summary Compensation Table&#x201d; totals to determine &#x201c;compensation actually paid&#x201d; as reported in the &#x201c;Pay Versus Performance&#x201d; table above. For purposes of the equity award adjustments shown below, no equity awards were cancelled as a result of a failure to meet vesting conditions. The valuation assumptions used to calculate fair values for purposes of the compensation actually paid calculation did not materially differ from those disclosed at the time of grant (as applicable). The following table details the applicable adjustments to the amount in the &#x201c;Total&#x201d; column of the &#x201c;Summary Compensation Table&#x201d; in each applicable year that were made to determine &#x201c;compensation actually paid&#x201d; (all amounts are averages for the NEOs other than the PEO):&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="display: none; margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; display: none; text-align: center"&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; display: none; width: 100%"&gt;&lt;tr style="display: none; vertical-align: top"&gt;&lt;td style="display: none; width: 4%"&gt;&lt;span id="xdx_F02_zpnafTwdXRLe" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="display: none; text-align: justify; width: 96%"&gt;&lt;span id="xdx_F1B_zYYlWZfqUa2l" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;Represents the average of the amounts reported for the named executive officers (NEOs) as a group (excluding the PEO) in the &#x201c;Total&#x201d; column of the &#x201c;Summary Compensation Table&#x201d; in each applicable year. The names of each of the NEOs included for these purposes for 2023 and 2022 are Anthony Camarda, Robert Wild, Paul Severino and Tom KraMer.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0; display: none"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; display: none; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: top"&gt;
    &lt;td style="display: none; width: 4%"&gt;&lt;span id="xdx_F01_zkujJW59oU0h" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;(4)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="display: none; text-align: justify; width: 96%"&gt;&lt;span id="xdx_F18_zgxRZ7ecv2mg" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;Represents the cumulative total shareholder return of a fixed investment of $100 made at the closing price of the Company&#x2019;s common stock at September 30, 2021 for the measurement period beginning on such date and continuing through and including the end of the applicable fiscal year reflected in the table.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0; display: none"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; display: none; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: top"&gt;
    &lt;td style="display: none; width: 4%"&gt;&lt;span id="xdx_F08_zYsOItQPIN4i" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;(5)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="display: none; text-align: justify; width: 96%"&gt;&lt;span id="xdx_F1F_zkzAv4TKssd4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;Represents the amount of net loss reflected in the Company&#x2019;s audited financial statements for the applicable fiscal year reflected in the table.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;


</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="From2022-10-01to2023-09-30">Mr. Wise</ecd:PeoName>
    <ecd:PeoName contextRef="From2021-10-012022-09-30">Mr. Wise</ecd:PeoName>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="From2022-10-01to2023-09-30">&lt;p id="xdx_89A_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zlsifGlJe078" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Relationship Between Compensation Actually
Paid and our Total Shareholder Return&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Our stock price performance
is not one of the elements used in determining Compensation Actually Paid to our Named Executive Officers. However, the amount of Compensation
Actually Paid to our Named Executive Officers aligns with the Company&#x2019;s Total Shareholder Return (TSR) due to the fact that a portion
of the compensation paid to our Named Executive Officers is comprised of equity awards. In both 2023 and 2022, the amount of Compensation
Actually Paid to our Named Executive Officers was less than the Summary Compensation Table total for the Named Executive Officers due
to the decline in fair value of equity awards due in part to the declining stock price and TSR.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="From2022-10-01to2023-09-30">&lt;p id="xdx_897_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zu5kxKqi3YEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Relationship Between Compensation Actually
Paid and our Net Income (Loss)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;GAAP net income (loss) is a measure of our overall profitability that
we believe is a factor that can drive our stock price performance. However, Compensation Actually Paid is less sensitive to our annual
GAAP income (loss) because management and our Board does not believe that our GAAP income (loss) is the only meaningful measure in allowing
investors to evaluate management&#x2019;s performance, primarily due to: (i) losses incurred by our now discontinued retail segment which
the Board believes was as a result of supply chain issues and the pandemic which were outside of the control of our NEOs and (ii) the
need to retain key executives with the skills to provide the leadership the Company needs to succeed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:AdjToPeoCompFnTextBlock contextRef="From2022-10-01to2023-09-30">&lt;p id="xdx_847_eecd--AdjToPeoCompFnTextBlock_dU_zytiXv6xtgp" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Name&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Summary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Table Total&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Deduct
                                            &#x201c;Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Awards&#x201d;
    and&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&#x201c;Option&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Awards&#x201d;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;reported in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Summary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Table&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Add
                                            Year-&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;End Fair&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Value of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;and&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Unvested&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Granted in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;the Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Add
                                            (Deduct)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Year over&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Year Change&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;in Fair&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Value of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;and Unvested&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Granted in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Prior Years&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Add
                                            Fair&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Value as of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Vesting Date&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;of Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Granted and&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Vested in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;the Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Add&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;(Deduct)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Year over&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Year Change&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;in Fair Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;of Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Granted in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Prior Years&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;which&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Vested in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;the Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Add
                                            Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;of any&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Dividends&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;or Other&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Earnings&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Paid in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;the Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Actually Paid&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 19%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;PEO&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--PeoTotalCompAmt_c20221001__20230930_zAFWFGEd81nh" style="width: 6%; text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;337,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType1Member_zaIYdNAytuQg" style="width: 6%; text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType2Member_zQxLOZU7iwA1" style="width: 6%; text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType3Member_zfRvvYaME3o2" style="width: 6%; text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType4Member_zBFcxB2Cpvnj" style="width: 6%; text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType5Member_zmjH0KoiKOmg" style="width: 6%; text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType6Member_z20frLH60Nfi" style="width: 6%; text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType7Member_zd9xbeQk8rA8" style="width: 6%; text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;337,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;Other NEOs&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--NonPeoNeoAvgTotalCompAmt_c20221001__20230930_zBsKPOAEoe3l" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;304,945&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType1Member_z6AdaeUPiUz4" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType2Member_zeduNCByvMza" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType3Member_zG29AeK9Zx0i" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;(1,210)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType4Member_zngEMF1uAVb" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType5Member_zkN6p0Vwi1Ub" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;(739)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType6Member_zzURSu7JyNQl" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--AdjToCompAmt_c20221001__20230930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType7Member_zQcIbIReSbQ6" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;302,996&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;PEO&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--PeoTotalCompAmt_c20211001__20220930_zhQzzGhso179" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;330,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType1Member_zIrAyk4ET7ul" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType2Member_zGSuWM8te49a" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType3Member_zpWdWuPpMutb" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType4Member_zkf2SssUjsJ9" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType5Member_zEIr9iRChxVg" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType6Member_zogKSv7PJr77" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AdjustmentType7Member_zFUCpOncRCv2" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;330,750&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;Other NEOs&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--NonPeoNeoAvgTotalCompAmt_c20211001__20220930_zbQSHayqaVpf" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;286,498&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType1Member_zjmIjnqyT9Pi" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;5,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType2Member_zLhJ4JMQwWgh" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;2,717&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType3Member_zxkCJlrwaJZf" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType4Member_zAZhVmwtIPwa" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;1,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType5Member_zIQzDjqxqpF4" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType6Member_z5UUG8KOJYec" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;0&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--AdjToCompAmt_c20211001__20220930__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AdjustmentType7Member_zn6BFSJmDmni" style="text-align: center" title="Summary Comp.Table Total for CEO"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;285,882&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 9pt"&gt;________________&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 96%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;Represents the average of the amounts reported for the named executive officers (NEOs) as a group (excluding the PEO) in the &#x201c;Total&#x201d; column of the &#x201c;Summary Compensation Table&#x201d; in each applicable year. The names of each of the NEOs included for these purposes for 2023 and 2022 are Anthony Camarda, Robert Wild, Paul Severino and Tom Kramer.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;(4)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;Represents the cumulative total shareholder return of a fixed investment of $100 made at the closing price of the Company&#x2019;s common stock at September 30, 2021 for the measurement period beginning on such date and continuing through and including the end of the applicable fiscal year reflected in the table.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;(5)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;Represents the amount of net loss reflected in the Company&#x2019;s audited financial statements for the applicable fiscal year reflected in the table.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-10-01to2023-09-30"
      decimals="0"
      unitRef="USD">337000</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType1Member"
      decimals="0"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType2Member"
      decimals="0"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType3Member"
      decimals="0"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType4Member"
      decimals="0"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType5Member"
      decimals="0"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType6Member"
      decimals="0"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-10-012023-09-30_ecd_PeoMember_custom_AdjustmentType7Member"
      decimals="0"
      unitRef="USD">337000</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2022-10-01to2023-09-30"
      decimals="0"
      unitRef="USD">304945</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType1Member"
      decimals="0"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType2Member"
      decimals="0"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType3Member"
      decimals="0"
      unitRef="USD">-1210</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType4Member"
      decimals="0"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType5Member"
      decimals="0"
      unitRef="USD">-739</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType6Member"
      decimals="0"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-10-012023-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType7Member"
      decimals="0"
      unitRef="USD">302996</ecd:AdjToCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2021-10-012022-09-30"
      decimals="0"
      unitRef="USD">330750</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType1Member"
      decimals="0"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType2Member"
      decimals="0"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType3Member"
      decimals="0"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType4Member"
      decimals="0"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType5Member"
      decimals="0"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType6Member"
      decimals="0"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-10-012022-09-30_ecd_PeoMember_custom_AdjustmentType7Member"
      decimals="0"
      unitRef="USD">330750</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2021-10-012022-09-30"
      decimals="0"
      unitRef="USD">286498</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType1Member"
      decimals="0"
      unitRef="USD">5000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType2Member"
      decimals="0"
      unitRef="USD">2717</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType3Member"
      decimals="0"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType4Member"
      decimals="0"
      unitRef="USD">1667</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType5Member"
      decimals="0"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType6Member"
      decimals="0"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-10-012022-09-30_ecd_NonPeoNeoMember_custom_AdjustmentType7Member"
      decimals="0"
      unitRef="USD">285882</ecd:AdjToCompAmt>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000015"
          xlink:label="Fact000015"
          xlink:type="locator"/>
        <link:footnote id="Footnote000040" xlink:label="Footnote000040" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the amounts reported for <xhtml:span id="xdx_908_eecd--PeoName_c20221001__20230930_zfxhn2CRcaT"><xhtml:span id="xdx_90F_eecd--PeoName_c20211001__20220930_zcxEelDByyNl">Mr. Wise</xhtml:span></xhtml:span> (the &#x201c;PEO&#x201d;) in the &#x201c;Total&#x201d; column of the &#x201c;Summary Compensation Table&#x201d; in each applicable year. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000015"
          xlink:to="Footnote000040"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000027"
          xlink:label="Fact000027"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000027"
          xlink:to="Footnote000040"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000017"
          xlink:label="Fact000017"
          xlink:type="locator"/>
        <link:footnote id="Footnote000043" xlink:label="Footnote000043" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">SEC rules require certain adjustments be made to the &#x201c;Summary Compensation Table&#x201d; totals to determine &#x201c;compensation actually paid&#x201d; as reported in the &#x201c;Pay Versus Performance&#x201d; table above. For purposes of the equity award adjustments shown below, no equity awards were cancelled as a result of a failure to meet vesting conditions. The valuation assumptions used to calculate fair values for purposes of the compensation actually paid calculation did not materially differ from those disclosed at the time of grant (as applicable). The following table details the applicable adjustments to the amount in the &#x201c;Total&#x201d; column of the &#x201c;Summary Compensation Table&#x201d; in each applicable year that were made to determine &#x201c;compensation actually paid&#x201d; (all amounts are averages for the NEOs other than the PEO):</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000017"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000021"
          xlink:label="Fact000021"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000021"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000029"
          xlink:label="Fact000029"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000033"
          xlink:label="Fact000033"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000033"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000019"
          xlink:label="Fact000019"
          xlink:type="locator"/>
        <link:footnote id="Footnote000044" xlink:label="Footnote000044" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the average of the amounts reported for the named executive officers (NEOs) as a group (excluding the PEO) in the &#x201c;Total&#x201d; column of the &#x201c;Summary Compensation Table&#x201d; in each applicable year. The names of each of the NEOs included for these purposes for 2023 and 2022 are Anthony Camarda, Robert Wild, Paul Severino and Tom KraMer.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000019"
          xlink:to="Footnote000044"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000031"
          xlink:label="Fact000031"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000031"
          xlink:to="Footnote000044"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000023"
          xlink:label="Fact000023"
          xlink:type="locator"/>
        <link:footnote id="Footnote000045" xlink:label="Footnote000045" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the cumulative total shareholder return of a fixed investment of $100 made at the closing price of the Company&#x2019;s common stock at September 30, 2021 for the measurement period beginning on such date and continuing through and including the end of the applicable fiscal year reflected in the table.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000023"
          xlink:to="Footnote000045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000035"
          xlink:label="Fact000035"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000035"
          xlink:to="Footnote000045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000025"
          xlink:label="Fact000025"
          xlink:type="locator"/>
        <link:footnote id="Footnote000046" xlink:label="Footnote000046" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the amount of net loss reflected in the Company&#x2019;s audited financial statements for the applicable fiscal year reflected in the table.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000025"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000037"
          xlink:label="Fact000037"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000037"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>30</ContextCount>
  <ElementCount>17</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>9</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="forward_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forwardindustries.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="forward_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ford-20230930.xsd</File>
    <File>ford-20230930_def.xml</File>
    <File>ford-20230930_lab.xml</File>
    <File>ford-20230930_pre.xml</File>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="forward_def14a.htm">forward_def14a.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
    <File>image_002.jpg</File>
    <File>image_003.jpg</File>
    <File>image_004.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="49">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "forward_def14a.htm": {
   "nsprefix": "FORD",
   "nsuri": "http://forwardindustries.com/20230930",
   "dts": {
    "schema": {
     "local": [
      "ford-20230930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "ford-20230930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ford-20230930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ford-20230930_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "forward_def14a.htm"
     ]
    }
   },
   "keyStandard": 17,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 2,
   "memberCustom": 7,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 30,
   "entityCount": 1,
   "segmentCount": 9,
   "elementCount": 103,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2023": 49,
    "http://fasb.org/us-gaap/2023": 2,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "report": {
    "R1": {
     "role": "http://forwardindustries.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2022-10-01to2023-09-30",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forward_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-10-01to2023-09-30",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forward_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2022-10-01to2023-09-30",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forward_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-10-01to2023-09-30",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forward_def14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r69",
      "r80",
      "r90",
      "r114"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://forwardindustries.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r110"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary Comp.Table Total for CEO"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "FORD_AdjustmentType1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://forwardindustries.com/20230930",
     "localname": "AdjustmentType1Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deduct \"Stock Awards\" and \"Option Awards\" Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r67",
      "r78",
      "r88",
      "r112"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://forwardindustries.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r84",
      "r94",
      "r110",
      "r118",
      "r122",
      "r130"
     ]
    },
    "FORD_AdjustmentType2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://forwardindustries.com/20230930",
     "localname": "AdjustmentType2Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Add Year-End Fair Value of Outstanding and Unvested Equity Awards Granted in the Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r76",
      "r84",
      "r94",
      "r110",
      "r118",
      "r122",
      "r130"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r66",
      "r77",
      "r87",
      "r111"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "FORD_AdjustmentType3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://forwardindustries.com/20230930",
     "localname": "AdjustmentType3Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Add (Deduct) Year Over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "FORD_AdjustmentType4Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://forwardindustries.com/20230930",
     "localname": "AdjustmentType4Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Add Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r68",
      "r79",
      "r89",
      "r113"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r66",
      "r77",
      "r87",
      "r111"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "FORD_AdjustmentType5Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://forwardindustries.com/20230930",
     "localname": "AdjustmentType5Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Add (Deduct) Year Over Year Change in Fair Value of Equity Awards Granted in Prior Years Which Vested in the Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "FORD_AdjustmentType6Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://forwardindustries.com/20230930",
     "localname": "AdjustmentType6Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Add Value of any Dividends or Other Earnings Paid in the Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r69",
      "r80",
      "r90",
      "r114"
     ]
    },
    "FORD_AdjustmentType7Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://forwardindustries.com/20230930",
     "localname": "AdjustmentType7Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r72",
      "r83",
      "r93",
      "r117"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r85",
      "r95",
      "r119"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://forwardindustries.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r70",
      "r81",
      "r91",
      "r115"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r65",
      "r134"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r82",
      "r92",
      "r116"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r65",
      "r134"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://forwardindustries.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r65",
      "r134"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r135"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r85",
      "r95",
      "r119"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r84",
      "r94",
      "r118"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r75",
      "r86",
      "r96",
      "r120"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://forwardindustries.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://forwardindustries.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001683168-24-000018-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-24-000018-xbrl.zip
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MTK#GP.H3UV[L;TB[!E5F(29"Q=G+]NCI2A6!K0LL@Q4O*[T!G(B$2@V;O]@
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M_RK;*7N/K23!+20Y3OTB^!J2BS1$2^6$L5F8.UKEF9 S.HSQE$RIT2UYI.F
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M@D5?8(L(L;$*ANY5+S@06NHCT(C<%'<;UC:!@D/A]'(7E8/,M*B6Z&N]P,3
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MD5>A!9X,   (IP  %0   &9O<F0M,C R,S Y,S!?<')E+GAM;.V=6W,:.Q*
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M/9IXF6,R[A0IN>%D)VZS,]PV\$EE_@7.'(2#0!JAY#J0\\=1#Z3?OV$L0 &
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MMIWB5?1$&VDD$9L3%40*A''KW6]2G;M"35E3SU&Q>=95A9Y<_Z+A]4:\87=
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M'*MWARZ*/259Z4]@2DP: =!N\1'0U:2*E-G:E13*"NU(>\]#61,U^1X1\7U
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M/*$7I-\!2/I.4G(2M,)X:/2S>#"@BD2 C;Y)Y+:'QG9071V$0=P>SAI_P *
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M&1;J0,V>.\"^3M$#6AGAJE#()46DYY2,\-M6X0)F-2[3'<D(YA14;P(.,-9
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M8",%[53AV1G>I8-G=O=<"AXEZ?L]<F&#+J)L1E*-U66$=5H=.K@)>#>N^):
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M,?\!N/'N!][N(L"O54C+RR:EW\73_C3IC9EPO&+A0B'WG41N":5A2='&D0A
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MVS9$5C\;!<6".H:=5T9&3I40@<"G" Q-5(J%+%5A3Q*5<TPTP\_7#M6!L*_
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MV4H!+[/?>,N)!=>U/=JJ?ZT]M]F\FA^77(*IL+-W+^1<[ERD2Y^XV#)<M+Q
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MJ4N4);5RN7]_>,QU$[C]T3U3MJ;9:V1M<_+4280IJSU06]G?F>9*JF;?,WT
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MY"KP6M!H8;.O!AR]-V"%?5X4F!]TQR SACQ&7 VP'1S54 T<HM-#>AJ &F
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ML P/X=A?C^JD@^ ;-JD>S.I*6GU-KB9)BN:;HI%-;.."U0%7Q#J_9NI&^(1
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M J-6(@&D25PWX"8=GTRLXKVR0X4%;1H X^@/W19/T,_O[^V0CY\2%V L/20
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MR!\\/"').U%:H^O8@B42H8NNG26.'M L]/S0<!36$*OTB4')917QUCU),=J
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M2*'MBD(=$$W0%UT)N_[1QF7G-LS K_\-4$L#!!0    ( *R (EA34:8YE@4
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M+3(P,C,P.3,P+GAS9%!+ 0(4 Q0    ( *R (EB;K-,F&00  "\?   5
M          "  ?,#  !F;W)D+3(P,C,P.3,P7V1E9BYX;6Q02P$"% ,4
M" "L@")885YJFOT0  #/V0  %0              @ $_"   9F]R9"TR,#(S
M,#DS,%]L86(N>&UL4$L! A0#%     @ K( B6)%7H06>#   "*<  !4
M         ( !;QD  &9O<F0M,C R,S Y,S!?<')E+GAM;%!+ 0(4 Q0    (
M *R (E@KX:H[/<<  -:-!@ 2              "  4 F  !F;W)W87)D7V1E
M9C$T82YH=&U02P$"% ,4    " "L@")8Y<;4EVD&  #T!@  #0
M    @ &M[0  :6UA9V5?,# Q+FIP9U!+ 0(4 Q0    ( *R (EA34:8YE@4
M # &   -              "  4'T  !I;6%G95\P,#(N:G!G4$L! A0#%
M  @ K( B6)F1\&I'!0  VP4   T              ( ! OH  &EM86=E7S P
M,RYJ<&=02P$"% ,4    " "L@")8I0BC-:X'   X"   #0
I@ %T_P  :6UA9V5?,# T+FIP9U!+!08     "0 ) #0"  !-!P$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
